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ABSTRACT
Activation of the innate immune system is a prerequisite for the induction of
adaptive immune responses to both infectious and non-infectious agents. Toll-like
receptors (TLRs) are a family of proteins important for recognizing pathogen
associated molecular patterns. MyD88 is an adaptor molecule whose function is
critical in TLR signaling. MyD88-deficient (MyD88-/-) mice exhibit heightened
susceptibility to infections, even by attenuated strains of Salmonella enterica
serovar Typhimurium. Paradoxically, despite their hypersusceptibility, infected
MyD88-/- mice produce elevated serum levels of anti-Salmonella antibodies
regardless of the route of infection. This hypergammaglobulinemia was observed
with both Th1-driven (IgG2c and IgG3) and Th2-driven (IgG1) antibody isotypes.
The dysregulated antibody responses also led to the production of autoantibodies
as demonstrated by reactivity to dsDNA and thyroglobulin, positive nuclear
staining with HEp2 cells, and immune complex deposition in the kidneys of
MyD88-/- mice. Utilizing intracellular cytokine staining, real-time PCR and 6color flowcytometric analysis, we demonstrated that these autoimmune responses
correlate with the activation of distinct populations of IFN-+/IL-4+ and IFN+/IL10+ T helper lymphocytes. Further analysis revealed that these most likely
represent a specialized family of cells known as follicular helper T cells (TFH
cells) which function to promote B cell activation and antibody production. The
aberrant expansion of these TFH-like cells could underlie the activation of
autoreactive B cells leading to humoral autoimmunity. Our findings highlight a
critical role for TLR-MyD88 pathway in controlling reactivity to self-antigens and
provide a potential mechanism for the inter-relationship between microbial
infections and autoimmune disease development in humans.
vi
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الملخص
تحفيز جهاز المناعة الفطري شرط أساسي لتنشيط جهاز المناعة التكيفي تجاه العوامل المعدية وغير المعدية.
المستقبالت شبيهة التول ) (TLRsهي مستقبالت مهمة الستشعار األنماط الجزيئية المرافقة للكائنات
الممرضة و التي تعتمد على الجزيء الناقل  Myd88لنقل اإلشارة داخل الخلية .عند إجراء التجارب على
الفئران المفتقرة ل (MyD88-/-) MyD88وجد أن لديهم قابلية عالية للموت لدى إصابتهم بالعدوى حتى
بأنواع مضعفة من السالمونيال  .Salmonella enterica serovar Typhimuriumبعد إصابة هذه
الفئران بعدوى السالمونيال ،لوحظ أنهم أنتجوا كميات كبيرة من األجسام المضادة ضد السالمونيال من كال
نوعي الخاليا المساعدة  Th-1و Th-2بغض النظر عن طريقة العدوى و هذه الظاهرة تعرف بفرط جاما
جلوبين الدم ) .(hypergammaglobulinemiaفرط جاما جلوبين الدم ترافق مع نشاط بعض هذه األجسام
المضادة إلى مولد الضد الذاتي حيث تفاعلت مع الحمض النووي و الثايروجلوبين ،كما وجدت ترسبات
للمتراكبات المناعية في الكلية .باستخدام عدة تقنيات ،تمكنا من تحديد عالقة بين االستجابة الناعية الذاتية و
وجود نشاط لمجموعة مميزة من الخاليا التائية المساعدة IFN-γ+/IL-4+و  ، IFNγ+/IL-10+كذلك تبين
لنا أن هذه الخاليا على األغلب هي من عائلة متخصصة تسمى بالخاليا الجريبية التائية المساعدة (TFH
) cellsو التي لها دور في تعزيز نشاط الخاليا البائية و دفعها إلنتاج األجسام المضادة .و قد يفسر وجود
شذوذ في توسع للخاليا شبيهة الخاليا الجريبية التائية المساعدة نشاط الخاليا البائية النشطة ذاتيا المسببة
ألعراض أمراض المناعة الذاتية .في الختام ،دراستنا توضح أهمية مسار المستقبالت الشبيهة بالتول و
بروتين  MyD88في التفاعل مع مولدات الضد الذاتية و تقترح آلية تربط اإلصابة بالعدوى و نشئة أمراض
المناعة الذاتية عند اإلنسان.
كلمات داللية:
المناعة الفطرية ،المستقبالت الشبيهة بالتول ،فرط جاما جلوبين الدم ،عدوى السالمونيال ،الذئبة الحمراء
الجهازية ) ، (SLEأمراض المناعة الذاتية.
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1. INTRODUCTION
The two main elements of the host immune defense system include the innate
and adaptive immunity whose components target infectious agents like microbes
and non-infectious agents such as adjuvants. Effective host defense against
microbial infections is dependent on prompt recognition of pathogens, rapid
induction of immediate anti-microbial defense mechanisms and ultimately the
activation of strong, antigen-specific, lymphocyte responses. The innate immune
system is an evolutionary conserved system that recognizes and responds to a
wide range of microbial pathogens. It plays a crucial role in the initial control of
infections and is mediated by phagocytic cells and antigen presenting cells
(APCs). These cells recognize evolutionary conserved components of the
pathogen essential for their survival and pathogenicity known as pathogen
associated molecular patterns (PAMPs) through the host germline encoded pattern
recognition receptors (PRRs). Several families of PRRs have been identified
which include TLRs (Toll like receptors), RIG (retinoic acid-inducible gene 1 like
receptors) and NLRs (nucleotide-binding oligomerization domain like receptors)
all of which play a central role in the host defense (Kumar et al., 2011).
1.1. Toll like receptors
TLRs, a family of one of the most extensively studied PRRs, is a class of
conserved type 1 transmembrane structures that identify PAMPs through the
process of pattern recognition (Takeda et al., 2003). This in turn leads to the
initiation of a series of signaling cascades, resulting in the transcriptional
expression of genes that code for inflammatory cytokines, chemokines and costimulatory molecules (Akira et al., 2006); (Kopp and Medzhitov, 2003);
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(Medzhitov, 2007) depending on the type of cells activated. Some examples
include secretion of TNF-α by murine macrophages on activation of TLR4 and
TLR2 (Jones et al., 2001) On recognition of viral associated patterns, TLR
activation on NK cells leads to production of GM-CSF (granulocyte-monocyte
colony stimulating factor) and IFN-γ (Adib-Conquy et al., 2013).
The first member of the TLR family was a protein identified in Drosophila
melanogaster (fruit fly). Drosophila Toll was found to play a crucial role in host
response to fungal infections as well as dorso-ventral patterning during
embryogenesis in the fruit fly (Lemaitre et al., 1996). Several mammalian
homologues of the Drosophila Toll protein have been identified and shown to
induce the expression of genes involved in the inflammatory response. One such
example is TLR1-5 that has been found to be more closely linked to the Toll
homologs of Drosophila (Rock et al., 1998); (Medzhitov et al., 1997).
About 13 mammalian TLRs have been cloned in mammals of which TLR1-9
are conserved between mouse and human. Each of them recognizes distinct
molecular patterns derived from viruses, pathogenic bacteria, pathogenic fungus
and parasitic-protozoa through their PRRs (Akira et al., 2006); (Janeway, 1989).
They are expressed in many immune cells such as B cells, dendritic cells (DCs),
macrophages (antigen presenting cells) and certain types of T-cells as well as nonimmune cells like fibroblast and epithelial cells (Iwasaki and Kelsall, 1999);
(Iwasaki and Medzhitov, 2004); (Akira et al., 2006). Most TLRs are expressed on
the cell surface, which include TLR 2, 4, 6, 8 and 10 while some like TLR3, 7 and
9 are expressed intracellularly (Akira et al., 2006); (Kawai and Akira, 2010)
(Table 1). Members of the TLRs subfamily within the cell are localized on the
membrane of intracellular vesicles, such as endosomes and lysosomes where they
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identify the nucleic acid components of pathogenic organisms (Medzhitov, 2007).
TLRs are found as individual units or as pair as well as with a range of other
signaling molecules.
TLR

Ligand

Microbial source

TLR1

triacyl lipopeptides

bacteria

TLR2

peptidoglycans, lipoproteins,
atypical LPS, zymosan,
phospholipomannan, GPI
anchors, heat-shock proteins
(e.g. HSP 70)
poly I:C, dsRNA

bacterial, fungi, protozoa,
host cells

bacterial, fungi, protozoa,
virus host cells

TLR5

LPS, mannan,
glucuronoxylomannan,
glycoinositolphospholipids,
RSV fusion protein, heat-shock
proteins (e.g. HSP 60)
flagellin

TLR6

diacyl lipopeptides

bacteria

TLR7

virus

TLR8

synthethetic imiazoquinolinelike molecules, ssRNA
ssRNA

TLR9

CpG DNA

bacteria, protozoa, virus

TLR10

function and ligand unknown

-

TLR11 (mouse only)

components of uropathogenic
bacteria, profillin like
molecules
function and ligand currently
unknown

bacteria, protozoa

TLR3
TLR4

TLR12-13 (mouse
only)

virus

bacteria

virus

-

Table 1: Toll like receptors and pathogen recognition (Adapted from
Chong D.L.W. Sriskandan S. Herwald H, Egesten A (eds): Sepsis – Pro-Inflammatory
and Anti-Inflammatory Responses. Contrib Microbiol. Basel, Karger, 2011, vol 17, pp
86–107)

These evolutionarily conserved proteins are characterized by an extracellular
ligand binding N terminus domain made up of leucine rich repeats (LRRs) and an
intracellular C terminus domain homologous to IL-1 receptor (Bowie and O'Neill,
2000); (Medzhitov, 2007). The intracellular Toll IL-1 receptor (TIR) region
consists of around 200 amino acids and is involved in signal transduction (Bauer
et al., 2008); (Bowie and O'Neill, 2000). Protein–protein interaction is mediated
by the TIR domain, one of the earliest motifs to be involved in signaling
3

(Kimbrell and Beutler, 2001). Binding of the TLR to its ligand reveals the
presence of an infection which leads to the activation of the immune system and
elimination of the pathogen.
Upon binding to their respective ligands, TLRs generate signals through the
recruitment of adaptor molecules such as MyD88 (myeloid differentiation primary
response 88), TRIF (TIR-domain-containing adapter-inducing interferon-β),
TIRAP (TIR domain containing adaptor protein) and TRAM (TRIF related
adaptor molecule) via the TIR cytoplasmic domain. This stimulates the production
of reactive oxygen and nitrogen intermediates (ROI and RNI). TLR signaling
induces the production of pro-inflammatory cytokines, type 1 interferons as well
as enhances the expression of co-stimulatory molecules. This leads to the
activation of APCs, subsequently initiating the adaptive immune response
(Werling and Jungi, 2003).
The MyD88 (myeloid differentiation factor 88) is the central adaptor
molecule used by all TLRs except TLR3. The pathway initiates the expression of
NF-kB or interferon-regulatory transcription factor (IRF-1) that are involved in
the regulation of inflammation and activation of pathogen specific adaptive
immunity (Kumar et al., 2009); (Akira, 2003). MyD88 is also involved in the
signaling pathway of IL-1 and IL-18 receptors. This adaptor molecule recruits IL1 receptor-associated kinase-4 (IRAK-4) to TLRs through the death domain
interaction of both molecules. By phosphorylation, IRAK-1 is activated and
induces the interaction of TNF-receptor associated factor (TRAF6). TRAF6 then
activates TAK1 complex through ubiquitination. TAK1 in turn leads to the
subsequent activation of IκB kinase (IKK) complex. This catalyzes IκB and its
degradation results in the release of NF-κB. The transcription factor once liberated
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translocates into the nucleus and induces gene expression of the target
inflammatory cytokines to the infection (Akira, 2003). TAK1 also activates the
mitogen activated protein (MAP) kinase pathway that eventually leads to the
activation of activator-protein (AP-1) and NF-κB. Meanwhile, TLR4 possesses a
MyD88 dependent and a TRIF dependent pathway, whereas TLR3 signal only
through TRIF. Signaling through TRIF adaptor molecule leads to the recruitment
of TBK1 together with IKKi that result in the phosphorylation of IRF3. Once
phosphorylated, IRF3 dimerizes and translocates to the nucleus and binds to the
DNA. TRIF can also bind to TRAF6 and receptor-interacting protein (RIP-1) that
mediates the activation of NF-κB. For the induction of type1 interferons (IFNs),
activation of IRF3 and NF-κB are required (Fig. 1). On stimulation through TLR
ligands, DCs and macrophages are the major producers of inflammatory
cytokines.

Fig. a. Toll like receptor signaling. T Kawai and S Akira. Cell Death and
Differentiation (2006) 13, 816–825.
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1.1.1. Control of adaptive immune response by TLRs
Activation of the innate immune cells by TLR ligands initiates adaptive
immune responses (Fig.2). On recognition of PAMPs through TLRs on dendritic
cells and macrophages, costimulatory molecules and major histocompatibility
complex (MHCII) molecules are upregulated. Signaling through the receptors
induces the production of cytokines like IL-12, chemokines and nitric oxide. The
increased expression of CD80/86 and CD40 on DCs along with the presence of
IL-12 leads to the activation of CD4+ T cells and its differentiation to T helper-1
(Th1) cells (Werling and Jungi, 2003). TLR4 ligand like LPS can direct dendritic
cell maturation through enhanced expression of CD86 which is important for the
development of Th2 responses (Dabbagh et al., 2002). TLR2 activation through
peptidoglycan and zymosan ligands induce increased IL-10 production from DCs
(Qi et al., 2003) that is involved in the differentiation of Th2 cells (Iwasaki and
Kelsall, 1999). The differentiation of CD4+ T cells to effector T cells is controlled
by transcription factors. A very recent study has shown that IRF4 transcription
factor in DCs drives Th2 differentiation (Williams et al., 2013). GATA-3 is the
master regulator for Th2 responses promoting IL-4 production (Zheng and Flavell,
1997), while T-bet drives Th1 lineage and IFN-γ production (Szabo et al., 2000).
Loss of T-bet impairs Th1 response and by default commits to Th2 cell lineage
(Matsui et al., 2005). TLR2 signaling has been shown to be involved in expansion
of Treg cells (Netea et al., 2004) and TLR2 and TLR4 in promoting Th17
responses (Reynolds et al., 2010); (Higgins et al., 2006). Synergistic effect of
TLR2 and TLR7/8 agonists on DCs drives T cell differentiation to Th2/Th17 cells
(Matsui et al., 2005). This is due to the lack of production of IL-12p70 on
activated DCs (Wenink et al., 2009). TLR7 activation on DCs reduced Foxp-3
6

levels and the suppressive function of regulatory T cells through IL-6 production
(Hackl et al., 2011). Th1/Th2 differentiation is also determined by the amount of
antigen involved in the TLR activation of DCs (Sun and Pearce, 2007). At high
doses of Ova-peptide, splenic DCs induced Th1 development, while low doses
induced Th2 responses (Boonstra et al., 2003). In another study, high doses of
LPS through TLR4 failed to induce Th2 cell responses but rather induced IL-12
production resulting in Th1 response (Eisenbarth et al., 2002). Thus, the activation
of T cell subset largely depends on the TLR signals on APCs, the cytokine milieu
and the dose of antigen involved.

Fig. b. Toll-like receptors and innate immunity. Ruslan Medzhitov. Nature Reviews
Immunology 1, 135-145 (November 2001)

Some TLRs are expressed on T cells, though their level of expression is
variable. They are found to behave as costimulatory molecules and have a direct
effect on T cell responses (Rahman et al., 2009); (Komai-Koma et al., 2004). One
such example is the engagement of TLR1/2 through Pam3CysSK4 ligand on
activated CD8+ T cells that leads to enhanced CD8+ T cell proliferation and
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survival (Cottalorda et al., 2006). Stimulation of TLR5 on Tregs with flagellin
enhances the expression of Foxp-3 and Treg suppressive activity (Crellin et al.,
2005). The type of T cell differentiation generated largely depends on the category
of molecular pattern/ligand that is recognized by its respective TLR (Tipping,
2006).
Since APCs are involved in initiating the adaptive immune response, it is of
relevance to investigate the role of TLRs in altering the adaptive immunity. A
defect in one or more components of the pathway exhibited, increased
susceptibility to a variety of pathogens examined in mice and humans which
underlines the importance of TLR-MyD88 interaction in recognition of microbial
pathogens (Campos et al., 2004); (Scanga et al., 2004).
1.2. Autoimmunity
The concept of autoimmunity as a cause for the development of disease in
humans has been accepted into the field of medical science since the 1950’s. It
was first predicted in the beginning of the twentieth century by the Nobel Laureate
Paul Ehrlich in his proposed idea of ‘horror autotoxicus’ wherein an immune
response against one’s own body tissues does not occur in a ‘normal’ being. An
autoimmune disease develops when the immune system starts attacking selftissues as a result of failure of self-tolerance, resulting in an aberrant immune
response. There is no individual theory that can fully explain the phenomenon of
autoimmunity or the development of autoimmune diseases. Several factors are
implicated in autoimmunity which include environmental triggers, immunological
and hormonal factors and genetic variants. Most autoimmune diseases can only be
treated but not cured because their target of self-antigen cannot be eliminated.
Self-tolerance can be broadly classified into central tolerance and peripheral
8

tolerance. In central tolerance the immature self-reactive lymphocytes are deleted
by apoptosis in the primary lymphoid organs, like bone marrow and thymus.
Apoptosis is driven by the high affinity of T cells to MHCII in combination with
self peptides and high affinity of B cell receptor (BCR) to naïve antigen for B
cells. Although the process of central tolerance is efficient, it cannot fully
eliminate all self-reactive lymphocytes partly because not all self antigens are
expressed in the central site of lymphocyte development. Autoimmune regulator
gene (AIRE) mainly expressed on medullary thymic epithelial cells (Kyewski and
Klein, 2006) induces the expression of tissue-specific antigens, necessary for the
negative selection of autoreactive T cells. In peripheral tolerance, the self antigens
that are encountered by the mature self-reactive B and T lymphocytes in
peripheral organs are eliminated through anergy (intrinsic biochemical changes
that reduce the activation of self-reactive receptors on cells), deletion or
suppression by Treg cells (Rioux and Abbas, 2005); (Gregersen and Behrens,
2006); (Xing and Hogquist, 2012). These cellular strategies act as checkpoints in
the pathway for the differentiation of lymphocytes, production of antibodies and
effector T cells. When self-reactive lymphocytes escape these mechanisms of
tolerance and get activated, autoimmune disease develops.
In the lymphoid organs, the major B cell subsets are the transitional (newly
emigrant) B cells, marginal zone and follicular B cells. The main mechanisms in
regulating B cell tolerance during its development include deletion, receptor
editing and anergy. Rag genes that catalyze VDJ recombination are persistently
expressed, enabling BCR receptor editing (Jankovic et al., 2004) in the immature
B cells. Rag expression is first induced during gene assembly of immunoglobulin
heavy chain (Allman et al., 1999); (Alt et al., 1984) and second, when pre-B cells
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stop their division during genetic recombination of Ig light chain (Li et al., 1993).
As B cells mature, their level of Rag expression is lowered. The self-reactive BCR
do not undergo prolonged receptor editing. Some reports have also highlighted the
expression of Rag in the germinal centers of spleen and Peyer’s patches (Han et
al., 1996) as well as in B cells activated in vitro and in vivo (Hikida et al., 1996).
Through the process of receptor editing which is at a frequency of 30-35%, those
cells with non self-reactive Ig L and H chain are positively selected. Mature BCR
is expressed on immature B cells in the form of IgM. Those immature B cells with
high avidity interactions with multivalent membrane bound self-antigens are
arrested and undergo elimination through apoptosis within the bone marrow
(Hartley et al., 1993a). During B cell development in the bone marrow, the
majority of antibodies from early immature B cells were autoreactive with antinuclear affinity (Wardemann et al., 2003). Several studies have shown that about
80% of the immature B cells are deleted before they reach the mature B cell
compartment in the spleen, suggesting a large population of autoreactive B cells in
the initial repertoire (Pieper et al., 2013); (Sidman and Unanue, 1975); (Norvell et
al., 1995); (Pieper et al., 2013). In the process of central B cell tolerance, the
immature B cell with prolonged and excessive levels of BCR cross linking to self
antigens, promptly internalizes the BCR thereby arresting its maturation (Hartley
et al., 1993b); (Nemazee and Hogquist, 2003). In the course of their halt, the
acquisition of adhesion molecules, such as CD62L homing receptors, which are
necessary to migrate to lymph nodes, is blocked (Hartley et al., 1993a). Nemazee
and colleagues have shown that gene rearrangement can edit the specificity of
autoreactive BCR, thus rescuing the cells from clonal deletion (Nemazee and
Hogquist, 2003). Other mechanisms of B cells escaping the primary lymphoid

10

organ include intermediate BCR signals and the ignorant state of self-reactive B
lymphocytes to antigens. The majority of the immature B cells undergo receptor
editing. However, this process also selects B cells that express two or more Ig L
and H chains that largely react to self-antigens. As a result, B cells that co express
autoreactive and non autoreactive BCRs get in to the mature peripheral B cell
populations (Li et al., 2002); (Liu et al., 2005). B cell activating factor (BAFF) is
crucial for peripheral B cell survival and their maturation. The level of expression
of BAFF-R on immature non self-reactive B cells is associated with their tonic
BCR signaling. Unlike non autoreactive B cells, immature autoreactive B cells
express low levels of BAFF-R that correlate with their insufficient BCR tonic
signaling (Rowland et al., 2010). Enhanced BAFF expression that causes
increased B cell expansion is known to be linked to autoimmunity. Elevated level
of the cytokine is observed in the serum of autoimmune patients (Migita et al.,
2007); (Pers et al., 2005); (Mackay et al., 2003); (Mackay and Browning, 2002).
During thymic development, T cells are selected based on their interaction
with the MHC protein-bound with the self peptide fragments of antigen. Those
developing T cells that express TCR with intermediate affinity to self-peptide
MHCII complex are positively selected and mature to CD4+ T/CD8+ T cells.
Double positive thymocytes that express TCR that do not bind to the self-peptide
MHC complex are unable to survive and die by apoptosis. Polyclonal thymocytes
that bind to self antigens are deleted in the cortex but those tissue specific or
circulating antigens are deleted in the thymic medullary region. The positively
selected thymocytes in the cortex move to the medulla trigger signals that induce
expression of homing receptors and TCRs. On moving to the medulla, the
thymocytes are still tested for their self reactivity where the medullary epithelial
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cells and dendritic cells express costimulatory molecules like CD80, CD86 and
CD28L for T cells (Derbinski et al., 2005). In this stage, those cells that bind
strongly to self-peptide MHC complexes under the control of autoimmune
regulatory AIRE gene, undergo clonal deletion (Goodnow et al., 2005). It has
been shown that AIRE-deficient mice possessed disordered medulla (Gillard et al.,
2007); (Dooley et al., 2008) with altered maturation of thymocytes and reduced
accumulation of Treg cells (Lei et al., 2011). Another process of tolerance
mechanism is through clonal diversion where self-reactive clone from T cell
repertoire induce Treg differentiation thus attaining immunoregulatory function
(Xing and Hogquist, 2012).
T cell differentiation and their effector functions require two signals, the first
of which is the antigen and the secondary signal is provided through costimulatory
molecules on APCs. Costimulatory signals largely determine the activation or
deletion of T lymphocytes. Not all self-antigens are expressed in the primary
lymphoid organs; some can be expressed from sequestered tissues or through
developmental antigens. Thus, tolerance mechanisms of deletion and anergy of
self-reactive clones take place in the periphery. In the process of peripheral
tolerance as mentioned earlier, a state of unresponsiveness or anergy can be
generated in self-reactive lymphocytes. This is mainly through the repression of
IL-2 expression and TCR signaling, as a result of interaction with APCs that do
not possess adequate levels of costimulatory molecules and through activation of
CTLA-4 on Tregs. Mice deficient in CTLA-4 develop spontaneous autoimmunity
(Waterhouse et al., 1995); (Tivol et al., 1995). An increased degree of autoreactive
T cells accumulate in lymphoid tissues in the absence of CTLA-4 (Walker and
Abbas, 2002). Furthermore, several nutrient sensing pathways have been
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identified in mediating T cell anergy. Some of these include activation of ATPdeprivation sensor, adenosine signals and others. Tolerogenic DCs that arise from
incomplete maturation also regulate tolerance. These peripheral tolerogenic DCs
fail to provide effective signals for T cell activation and proliferation (Xing and
Hogquist, 2012). Peripheral deletion of autoreactive lymphocytes is mediated
through Fas (death-domain-containing receptor) and Bim (BCL-2-interacting
mediator of cell death) apoptotic pathways. As T helper cells are required for the
activation of B cells, T cell tolerance is the most crucial process to maintain
peripheral B cell tolerance (Goodnow et al., 2005); (Xing and Hogquist, 2012), as
the B cells remain functionally unresponsive or undergo death by apoptosis due to
specific T helper cells that are either deleted or anaergic. Newly formed immature
B cells on migration to the spleen can encounter self antigens that are absent in the
bone marrow. Similarly these cells are rapidly deleted due to high avidity
interaction with the peripheral self-antigens (Goodnow et al., 2005). Also, B cells
that have low affinity for self antigens can be rendered unresponsive through
inhibitory receptor engagement and lack of signaling through NF-ƘB. In a varied
repertoire of B cell population, mature B cells that have escaped clonal deletion in
the bone marrow have a greater requirement for BAFF for their survival and being
weak competitors, they are unable to express high levels of BAFF-R and are thus
deleted (Lesley et al., 2004). Within the germinal centers, somatic hypermutation
and affinity maturation increases B cell specificity. These processes however, can
result in the generation of self-reactive receptors from formerly productive ones.
The survival of these cells is based on their affinity to self-antigens. They can be
eliminated because of competition for DC antigen presentation or T cell help
(Basten and Silveira, 2010).
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Genetic factors that lead to disease susceptibility are mainly caused by
complex traits that involve multiple genotypes and environmental factors such as
pathogen exposure, smoking etc. However, there are several single gene disorders
that have led to experimental models for the study of autoimmune diseases. The
genetic variants that lead to autoimmunity can be identified through various
genetic resources and tools. Genomic and proteomic approaches have made it
possible to understand the molecular basis of the diseases. Microarray analyses are
useful in determining the expression of hundreds of genes at the same time,
providing crucial information in the pathogenesis of the disease, its progression
and treatment (Fathman et al., 2005). Use of protein microarrays and assays based
on flow cytometry has been greatly adapted in proteomic studies in autoimmunity.
Numerous studies in complex human traits have reported the mapping of
susceptible loci. Some of these include identification of CTLA-4 locus in Grave’s
disease and type1 diabetes, PTPN22 locus in SLE, RA (Rheumatoid arthritis) and
type1 diabetes and Nod2 susceptible gene in Crohn’s disease (Rioux and Abbas,
2005). Also, most autoimmune diseases have been strongly associated with the
MHC region containing the HLA genes. Various animal models have been
valuable in investigating the general mechanism involved in these diseases. One
challenge in identifying genetic disorders is the product combination of genetic
repertoire and environmental factors. The versatility of the techniques in the study
of autoimmunity is limited and a multidisciplinary approach is required.
1.2.1. TLR signaling in B cell development

TLRs are expressed on early hematopoietic progenitor cells that help in
distinguishing between the self and non-self in the course of their development.
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TLR signaling commits the differentiation of myeloid progenitors to monocytes or
macrophages. MyD88-dependent signaling commits lymphoid biased progenitors
to potential DCs through cytokine production that influence differentiation
patterns (Nagai et al., 2006). An earlier study has implicated that signaling
through TLR7/9/ MyD88 is not essential for the positive and negative selection of
the B cell repertoire. They are however necessary for germinal center reaction and
antigen induced activation of B cells (Silver et al., 2006). On the other hand, study
by Isnardi et al. has identified the involvement of TLR signaling pathway during
B cell development where expression of TLR7, TLR10, IRAK and MyD88 was
detected in B cell fractions. They found that IRAK and MyD88 deficient B cells
had altered receptor editing leading to B cell precursor expressing ANA.
Moreover

IRAK/MyD88/UNC93B1

deficient

patients

possess

increased

frequency of naïve mature autoreactive B cells in the periphery (Isnardi et al.,
2008). These data suggest the role of TLR signaling in the removal of autoreactive
B cell lymphocytes and in maintenance of central and peripheral B cell tolerance.
1.2.2. Autoimmune mouse models
Autoimmune diseases can be classified into organ specific, that target
individual organs/tissues and systemic autoimmune diseases, characterized by
autoantibodies against wide variety of autoantigens. The development of several
inbred strains of mouse models, as a result of genetic and immunological
manipulation, have contributed significantly in understanding the pathogenesis
involved in autoimmune diseases. In spontaneous mice models, the autoimmune
disorder develops in a given mouse strain or as a result of crosses between
different strains, e.g non obese diabetic (NOD) mouse. In an induced model from
physical, chemical or biological factors, the animals generally develop
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autoimmunity, as a result of exposure to high concentrations of the self antigens
activating an immune response. Some examples of this model are experimental
autoimmune encephalomyelitis (EAE) for study of multiple sclerosis

and

collagen induced arthritis to study RA (Morel, 2004).
1.2.2.1. Systemic lupus erythematosus (SLE)
SLE is a complex multifactorial chronic autoimmune disease involving a
combination factor of genetic and environmental variants. The disease is
characterized by a systemic inflammation as a result of loss of B and T cell
tolerance. The exact mechanism in the occurrence of the disorder is challenging to
elucidate because of the combination of several susceptible gene loci. SLE
presents itself depending on the humoral and cellular responses established. The
distinct features of the disorder involve swollen joints, glomerulonephritis,
proteinuria, skin rash and respiratory disorders. Females are more susceptible to
the disease in both humans and mouse models of SLE. In order to understand the
genetic and pathological features of the disease, induced and spontaneous mouse
models of SLE have been studied. The spontaneous mouse strain models include
the New Zealand Black and New Zealand White (NZB/W) mice, MRL/lpr mice,
and BXSB/Yaa mice (Perry et al., 2010). Immunological manifestations in these
mice include B cell and T cell hyper activation, production of ANAs (anti-nuclear
autoantibodies), immune complex deposition and glomerulonephritis. Among the
three strains BXSB/Yaa mice exhibit a more severe glomerulonephritis. The
disease development in NZB/W mice is dependent on several susceptible genes on
both MHC and non-MHC loci (Kotzin and Palmer, 1987); (Kono et al., 1994);
(Rahman et al., 2002). The other two strains of the SLE model possess single gene
mutation. The MRL/lpr mice are developed from numerous crosses of inbred
16

strains of mice. Its phenotype was characteristic to an lpr mutation of the fas gene
located on chromosome 19. As a result, these mice show defective lymphocyte
apoptosis leading to massive lymphadenopathy and high amounts of circulating
immunoglobulins, including autoantibodies. The enlarged lymph nodes include
accumulation of double negative CD4-CD8- B220+ T cells. FasL gene mutation
located on chromosome 1 also called generalized lymphoproliferative disease
(gld) has shown to cause autoimmunity similar to that of an lpr mutation
(Takahashi et al., 1994). Overexpression of cytokines like IL-12 and NO has been
associated with pathogenesis in lpr syndrome (Huang et al., 1996). Also IL-4 and
IFN γ though play opposing roles in antibody production; their isotype switching
is indispensable in the development of autoimmunity in this spontaneous model.
Knockout mice on either of these cytokines produce significantly reduced titers of
their respective antibody isotypes along with decreased lymphadenopathy,end
organ disease and early mortality (Peng et al., 1997). IFN-γ dependent
autoimmune pathology has also been based on the hyper responsiveness of lpr/lpr
cells to IL-18 (Neumann et al., 2001). In BXSB mice, the disease is accelerated in
males due to mutation in the Yaa (Y linked autoimmune accelerator locus) containing Y chromosome. The genetic cause for Yaa involves the translocation
of TLR7 from the X chromosome onto the Yaa-containing Y chromosome. Along
with abnormal B and T cell activation, these mice display monocytosis and
lymphoid hyperplasia. Furthermore, it is the only model among the three that
develop antibodies to nuclear components of Smith (Sm) and ribonucleoprotein.
As a result of the genomic duplication, TLR7 ligand induced hyper responsiveness
has been reported. However, since multiple other genes are also being duplicated,
the exact role of this allele in accelerating the disease remains uncertain (Rottman
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and Willis, 2010). Through TLR7 transgenic mice, TLR7 overexpression leads to
spontaneous autoimmunity characterized by glomerulonephritis, autoantibodies to
RNA components and dendritic cell expansion. Moreover, a reduction in the
TLR7 gene dosage in the Yaa strain of mice abolishes their phenotype (Deane et
al., 2007). BXSB male mice deficient in IL-21R lacks the abnormal characteristics
of the Yaa mutant strain and seem highly resistant to the disease. This suggests the
IL-12 signaling pathway in playing an essential role in the pathogenesis of the
autoimmune disease in this SLE model (Bubier et al., 2009). Quantitative analyses
have revealed the susceptibility loci of BXSB on chromosomes 1, 3, and 13
(Bxs1-6) (Haywood et al., 2000). Some induced models of lupus include pristane
induced model and induced graft versus host disease. Intraperitoneal injections of
pristane into Balb/C mice generate autoantibodies and immune complex
deposition similar to that found in MRL/lpr mice (Satoh et al., 1995). Disease is
accelerated when pristane is administered to lupus-prone NZB/W F1 mice leading
to enhanced IL-12 secretion and autoantibodies to nuclear components (Yoshida
et al., 2002). The development of disease in this model is cytokine dependent as
IL-6 or IFN-γ deficient mice abrogate the SLE phenotype but not IL-4 deficient
mice (Richards et al., 1998); (Richards et al., 2001). Chronic graft versus host
disease (cGVHD) is induced by the transfer of mature T cells into
immunocompromised or semiallogenic recipient causing a cytokine storm ensuing
a chronic GVHD (Reddy P, 2009). CD4+ T knockout mice do not develop
autoantibodies or renal disease on allogeneic splenocyte transfer highlighting the
role of host endogenous T cells in cGVHD (Chen et al., 1998). Several potential
targets have been identified in therapy for SLE mouse models. Some of these
include the use of monoclonal antibodies against BAFF/BAFFR and cytokines
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that are known to accelerate disease such as IL-6, IFN-γ and TNF-α.
1.2.2.2. Multiple Sclerosis
Multiple Sclerosis is a complex inflammatory neurodegenerative disease of
the central nervous system. Some of the major theories that explain the cause of
MS include immunological as it is an immune mediated process, environmental
variations, infectious agents as trigger factor and genetic predisposition. The most
widely used and well known model of multiple sclerosis in humans is the
experimental autoimmune encephalomyelitis (EAE) in mice or rats. The disease is
induced in the animals by administration of myelin derived peptides in Freund’s
complete adjuvant, such as myelin oligodendrocyte derived protein (MOG) in
C57BL/6 mice (Farine, 1997); (Miller and Karpus, 2007). It can also be induced
in naïve recipients by adoptive transfer of encephalitogenic T cell blasts. In the
process, injection of the myelin antigens causes a breakdown of peripheral
tolerance leading to myelin specific T cell activation (Perl et al., 2004). The
disease is T cell mediated involving mononuclear cell infiltration of B cells, T
cells and macrophages in the brain and spinal cord through the blood-brain barrier
(Perl et al., 2004), by the help of expression of integrins (Yednock et al., 1992).
These infiltrating cells produce inflammatory cytokines and reactive oxygen
species that lead to the destruction of neuronal myelin sheath. The passive form of
induction of EAE that involves adoptive transfer of T cells from immunized
animals, helps in directly understanding the effector phase of the disease in the
CNS

(Katsnelson,

2012).

Theiler’s

Murine

Encephalitis

Virus-Induced

Demyelinating Disease (TMEV-IDD) is another related murine model for MS.
The principal mononuclear cells infected as a result of the virus are the
macrophages or the oligodendrocytes (Clatch et al., 1990). Owing to the
19

complexity of the disease, EAE has its own limitations, however, these mouse
models of demyelinating disease have played a significant role in better
characterizing the T cell mediated demyelination and CNS tissue injury.
1.2.2.3. Type1 diabetes (T1D)
Type1 diabetes mellitus also called juvenile diabetes (because of its early
onset of age) is another chronic organ specific autoimmune disorder that occurs in
genetically susceptible individuals through environmental factors. The disease is
due to the lack of insulin as a result of damage to the pancreatic β cells. The
inflammatory infiltrate in insulitis compromises mainly mononuclear cells, CD4+
and CD8+ T cells. The cause of destruction of the β cells has been strongly linked
to the highly polymorphic HLA class II molecules. Some of the autoantigens
recognized by the islet cell antibodies are the glutamic acid decarboxylase
(GAD65), protein tyrosine phosphatase–like molecule (IA-2) and thirdly insulin
protein. This has made possible it to identify individuals who are at a high risk of
developing T1D, before the clinical symptoms come in play. However, the
contribution of these antibodies in the pathogenesis is not clearly understood
(Notkins and Lernmark, 2001). The best known models of human type1 diabetes
in rodents are the non-obese diabetic (NOD) mouse and the BioBreeding (BB) rat.
The susceptibility to T1D in the NOD mice has been linked to the genetic loci of
the insulin-dependent diabetes (Idd) region, compromising multiple genes,
highlighting a large number of potential targets in the development of the disease
(Driver et al., 2010). In the spleen and lymph nodes of the NOD mice, the reactive
T cell clones to the islets has been known to be from both CD4+ T and CD8+ T
cells (Van Belle et al., 2009). In the NOD mice IL-2 defective production leads to
intra-islet Treg cell dysfunction, causing a breakdown of peripheral tolerance
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establishing a loss of balance between Treg cells and Teffector cells (Tang et al.,
2008). Another susceptibility of the NOD mice to the disease, is the variation in
the CTLA-4 gene that correlated with low mRNA levels of the CTLA-4 splicing,
contributing to the tissue damage (Ueda et al., 2003). The effector functions of β
cell autoreactive CD8+ T cells are MHCI dependent and can be negatively
selected by interaction with MHCII variants

(Serreze et al., 2004).

Cyclophosphamide, when administered at high doses in NOD mice, leads to an
aggravation of T1D and this has been associated with reduced CD4+CD25+Foxp3+
Treg population (Brode et al., 2006). A pathogen induced model of diabetes is the
lymphocytic choriomeningitis virus (LCMV) infection of the RIP-GP transgenic
mice under the control of the rat insulin promoter that result in the LCMV
glycoprotein expression in the pancreatic cells. As a result, the virus specific T
cells recognize the infected cells as well as the glycoprotein from the β cells
leading to an immune attack on these cells, causing an instant progress of the
disease (Van Belle et al., 2009). The NOD is the best used model to understand
the genetic causes of the human disease as well as to reverse the disease after
hyperglycemia appears. The disease can be prevented by cytokine alteration or by
activation of Treg suppressor cells so as to hinder effector cell functions (Farine,
1997).
1.2.2.4. Rheumatoid arthritis (RA)
RA is a heterogenous disease involving induced and spontaneous synovial
inflammation. No single gene is responsible for the expression of the disease due
to the polygenic genetic susceptibility, but genetics contributes to the overall
disease. Several inflammatory cytokines, like TNF-α, IL-1 and IL-6, are expressed
at high levels in the joints of individuals with RA (Lindqvist et al., 2002).
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Genetically, RA is linked with MHCII molecule HLA-DR4. The MrL/l mice
developed first by Murphy and Roths is a useful model for SLE, as mentioned
earlier. These mice exhibited IgM and IgG related rheumatoid factors (RF) and
polyarthritis, along with histological evidence of joint inflammation which are
among the features of human RA. The synovial immune response is a result of
interaction between T cells, B cells and macrophages and the joint disease was
closely linked with increase amounts of IgM RF and joint pathology (Hang et al.,
1982). Other transgenic mouse models that develop RA spontaneously are
(a) K/BxN mice in which immune response is elicited to enzyme G6P1 in a T cell
dependent manner and (b) human-TNF transgenic mice that express excess TNF-α
that is involved in the pathogenesis of arthritis (Bevaart et al., 2010). Some of the
induced animal models that have proved to be efficient in the study of RA in
humans are rat adjuvant arthritis, rat type II collagen arthritis and mouse type II
collagen arthritis. Adjuvant arthritis is developed by injecting mycobacterium in a
Freund’s adjuvant like mineral oil in the tail of the male Lewis rats (Farine, 1997).
Though this model develops robust polyarticular inflammation, it also shows bone
resorption and periosteal bone formation. The bone resorption can be inhibited by
inhibition of IL-1 in this model. In rat type II collagen arthritis, an emulsion of
bovine type II collagen in adjuvant is intradermally injected. This type of arthritis
is characterized by cartilage damage, immune complex deposits, bone resorption
and proliferation which are mediated by both B cells and T cells. Treatments with
soluble TNFR and IL-1ra have been useful as combination therapies (Bendele,
2001); (Bendele et al., 2000). This treatment is also useful for the other RA mouse
model of mouse type II collagen arthritis. In this model, the susceptibility has
been linked to the expression of MHCII haplotypes, particularly the H-2q
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haplotype (Bevaart et al., 2010). Another joint specific antigen like cartilage
proteoglycan is a candidate for inducing arthritis in mice in a Th1 cell mediated
disease and it resembles RA both genetically and pathologically (Otto et al.,
2000). Several treatments for RA have been approved some of which are the use
of cytokine inhibitors (against TNF-α, IL-6, IL-1) as well as T cell targeted
therapies.
1.2.3. Influence of infections in the development of autoimmunity
As we know, several environmental and genetic factors contribute to the
development of immune response to self antigens in the host body. Among the
environmental factors, infectious agents play a role as triggers of autoimmunity.
Cells of innate immune system, like the antigen presenting cells and B cells
possess receptors on the surface which can recognize or bind to the molecular
patterns of the pathogen. For an adaptive immune response to occur, an antigen
specific and a non-antigen specific signal is required. The antigen specific signal
is through the concept of molecular mimicry in which the antigenic patterns of the
invading pathogen resembles/mimics the antigenic determinants/self peptides of
the host tissue (Rose and Mackay, 2000). Such an infection causes the activation
of the local APCs, which in turn leads to the presentation of the self peptides. This
presentation results in the activation and expansion of T cells that cross react to
the self antigen, directly lyse the tissue cells and produce cytokines that activate
cells like macrophages and further mediate tissue damage and activate pathogen
specific B cells. This effect can also lead to the phenomenon of ‘epitope
spreading’ in the case of chronic infection of target organs or in chronic
autoimmune diseases. In this phenomenon an immune response that is initiated by
the existing pathogen or direct lysis by the pathogen leads to tissue damage. These
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antigens released from the injured tissue are engulfed by the APCs eliciting an
expanded immune response to the protein, leading to an intramolecular or
intermolecular epitope spreading of different self antigens. Acute phase proteins,
such as complement proteins, opsonize the micro-organism and have the ability to
bind to cellular debris of apoptotic cells, thus activating an antibody mediated
effector response (Gregersen and Behrens, 2006). In bystander activation,
pathogen specific T cells once activated, cause inflammation that injures the host
tissue and activates autoreactive T cells in a non-host specific manner (Delogu et
al., 2011). Another way that infections can lead to autoimmune response is
through changes in protein (post translational modification, misfolding or
mutations due to oxidative stress/free radical production) and exposure of cryptic
antigens to T cells that have escaped central and peripheral tolerance which were
invisible to the immune system and have now become immunogenic (Sfriso et al.,
2010). Proteins produced from microorganisms of bacteria, mycoplasma and virus
infected cells, called superantigens can directly bind to the TCR, regardless of
antigen specificities, resulting in the activation of a large number of T cells of
different antigenic specificities and functioning as a strong immune stimulating
molecule (Samarkos and Vaiopoulos, 2005). Overproduction of various
inflammatory cytokines including type1 interferon enhances the adaptive immune
responses. Viruses are known to initiate signaling through endogenous PRRs,
eliciting type1 IFN cytokines that have been associated with various autoimmune
diseases.
One of the well-known associations of autoimmunity in humans is infections
with viruses and bacteria. The concept of molecular mimicry was first noted in the
1980s where, by using monoclonal antibodies it was determined that the measles
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virus phosphoprotein and a human simplex virus (HSV) protein cross reacted with
different antigenic determinants of the intermediate filament protein in humans
(Fujinami et al., 1983). Human cytomegalovirus (HCMV) is a common
opportunistic pathogen with a long latency that targets several immune cells. This
virus induces immunological abnormalities like RF, ANAs and cryoglobulins and
lymphocytosis that has been linked to autoimmune diseases like RA, Sjodren’s
syndrome, Crohn’s disease and others. Increase disease activity in SLE patients
has also been associated with increase viral activity (Sfriso et al., 2010). In one
finding, about 15% of patients with T1D showed the presence of HCMVin the
lymphocytes which induces islet cell-specific antibodies that react with the human
islet cell protein (Pak et al., 1990). Through the mechanism of molecular mimicry
the epitope derived from the HCMV once processed and presented by the DCs is
recognized by GAD65 cross-reactive T cells (Hiemstra et al., 2001). A possible
association of Coxsackie B virus (CVB) with T1D has been suggested due to T
cell cross reactivity of GAD amino acid (enzyme expressed in the brain and β
cells in the pancreas) and P2-C protein (involved in viral replication) of the virus
due to their sequence similarity (stretch of 6 amino acid sequences) (Samarkos
and Vaiopoulos, 2005); (Tian et al., 1994). In rheumatic fever, infection with
Group A Streptococcus can lead to inflammation of the heart where myosin in the
heart has been known to be the dominant autoantigen. In this disease peripheral T
cell clones against the Streptococcal M protein were established to be cross
reactive and hence, proliferate in response to human myosin and laminin (Ellis et
al., 2005). Monoclonal antibodies that recognize the M protein and Streptococcus
carbohydrate epitope GlcNAc (Adderson et al., 1998) also cross-react with
myosin as well as DNA and keratin which was confirmed by the affinity of the
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non-myosin specific purified Abs from rheumatic fever patients to the myosin
proteins (Cunningham et al., 1988). Further supporting the concept of molecular
mimicry, Lunardi and group in their study identified a sequence of peptide that
shared homology with the VP1 protein of HCMV and human cytokeratin as well
as transcription factor GATA1 (Lunardi et al., 2008). GATA1 plays a crucial role
in megakaryopoiesis and erythropoiesis. The antiviral peptide antibodies were also
specific to collagen type II, single-stranded DNA, and cardiolipin (Sfriso et al.,
2010). Significant homology has been revealed between the myelin basic protein
and nucleoprotein of the hemagglutinin of influenza virus, hepatitis B virus
polymerase and others (Oldstone, 1998). In a murine model of herpes simplex
keratitis (HSK), local infection of HSV leads to inflammatory T mediated disease
in the cornea. Similarly in a murine myocarditis model, induction of Chlamydial
peptides that shared a similar sequence with the myosin peptide, caused
inflammatory heart disease in BALB/c mice (Wucherpfennig, 2001); (Bachmaier
et al., 1999). Another study revealed the neutralizing effects of monoclonal
antibodies

against

myocardial

CVB3.

These

antibodies

can

recognize

discontinuous epitopes on the viral capsid proteins as well as human/mouse
cardiac myosin and cardiac fibroblast, inducing chronic myocardial inflammation
(Gauntt et al., 1995).
Superantigens are able to bind to a range of class II MHC molecules and
TCR in a Vβ specific manner. Epstein Barr virus causes a lymphoproliferating
disease that leads to vast T cell activation of human VI3+ T cells due to possible
induction of K18.3 that possess superantigenic properties (Sutkowski et al., 1996).
Staphylococcal toxic shock syndrome toxin-1 and staphylococcal enterotoxin A
are the most commonly secreted T cell superantigens of the bacteria which
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additionally produce protein A, which is a B cell superantigen (Staphylococcus
aureus nasal carriage in rheumatoid arthritis). In one study, chronic exposure to
small amounts of superantigen-producing Staphylococcus aureus caused an
inflammatory systemic disease similar to SLE, characterized by infiltration of
mononuclear cells predominantly CD4+ T cells bearing TCR Vβ8 accompanied by
ANAs and glomerular deposits (Chowdhary et al., 2012). The enterotoxin A can

also trigger encephalitogenic MBP-specific non-Vβ8+ T cells to cause
experimental allergic EAE in PL/J mice (Soos et al., 1995). In chronic diseases
like Crohn’s disease, the role of superantigens have been emphasized due to the
increased percentages of Vβ8+ T cells in the mesenteric lymph nodes that drain the
inflammatory lesions (Posnett et al., 1990). In one finding Crohn’s disease has
been associated with I2 bacterial gene sequence that could be linked with disease
pathogenesis in patients (Sutton et al., 2000). This was confirmed in mice where
I2 was evidenced as a superantigenic stimulus that is a target of CD4+ Treg type
cells (Dalwadi et al., 2001). Some superantigens are also virally encoded such as
the protein coded by the open reading frame (ORF) gene of MMTV (Kay, 1995).
In other modes of development of autoimmunity from infections, Coxsackie
virus B3 can infect and lyse the cardiac myocytes directly, causing myocardial
destruction in SCID mice that can lead to autoimmunity through epitope
spreading. TMEV virus, a natural mouse pathogen, has been known to induce
CD4+ T cell mediated demyelinating autoimmune disease due to the release of
sequestered self-antigens that activate T cells which initially react to an
immunodominant peptide from PLP and later to peptides from myelin basic
protein and myelin oligodendrocyte (Miller et al., 1997).
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1.2.4. Influence of innate immunity in development of autoimmune diseases
An over activated response of the immune system to endogenous and
exogenous ligands contribute to the development of autoimmunity. A large
number of published data have established the involvement of the innate immune
system, particularly the TLRs, in the pathophysiology of autoimmune diseases.
Pattern recognition receptors like TLRs present on innate immune cells recognize
PAMPs and signal through the common adaptor MyD88 molecule, except for
TLR3 that signals in a MyD88 independent manner, leading to the downstream
transcription of interferon inducible genes (Interferon α/β). TLR9 recognizes
hypomethylated CpG motifs and TLR7 identifies viral ssRNA. Other intracellular
non TLR associated cytoplasmic receptors, like MDA-5 and RIG-1, recognize
viral components of dsDNA/dsRNA and activate the innate immune system.
Damage associated molecular patterns (DAMPs) released from dying cells contain
high mobility group box1, heat shock proteins, uric acid and other proteins which
function as alarmins and signal through TLRs inducing an inflammatory response.
Pathogen mediated cell damage or damage as a result of action of cytotoxic
lymphocytes, can enhance the antigen processing of the self peptides and increase
expression of costimulatory molecules that effectively activate the T cell
responses. Peripheral tolerance and activation of autoreactive T cells strongly
depend on the innate immune cell activation.
Some studies have highlighted the role of signaling through TLR3, TLR7 and
TLR9 in the production of autoantibodies and development of autoimmunity in
animal models of SLE. TLR3 expression was revealed in the glomerular
mesangial cells of the MRL/lpr mice and on injection with viral dsRNA, the
ligand was taken up by the mesangial cells and the infiltrating immune cells. This
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leads to an increase in the serum cytokine levels of IL-6, IL-12p70, and
IFN-α, eventually aggravating renal damage and proteinuria in the autoimmune
mice (Patole et al., 2005). TLR7 and TLR9 have been closely associated with
disease pathogenesis in SLE, one reason for this is their contribution to IFN-α
production. In a model of AM14 B cell transgenic cell line, immune complex
containing DNA/RNA gets internalized and the complex that triggers TLR7/9
results in B cell activation and early autoantibody production. Dual TLR and BCR
signaling have been implicated in the activation of auto-reactive B cells in AM14
B cells activation through MyD88 dependent TLR9 signaling (Rawlings et al.,
2012). A class of immature dendritic cells, called plasmacytoid DCs expressing
both TLR7 and TLR9 take up SLE-associated immune complex, leading to high
levels of IFN-α production. The FcγR-mediated nucleic acid delivery to the
TLR7/TLR9 of the DCs plays a vital role in the pathogenesis of SLE (MarshakRothstein, 2006). The influence of TLR9 in autoimmune MRL/lpr mice has been
conflicting in various published data. TLR9 deficient lpr mice display a different
HEp-2 immunofluroscent staining pattern consisting of a nuclear speckled pattern
(antibodies reactive to snRNPs), However, a homogenous one is observed in the
TLR9-intact lpr mice (Marshak-Rothstein and Rifkin, 2007). TLR9-/- MRL/lpr
mice have increased autoantibody titers with massive lymphadenopathy, severe
renal disease, proteinuria and mortality in comparison to the TLR9-sufficient mice
suggesting a protective role in TLR9 signaling through a potential Treg cell
function (Wu and Peng, 2006). A Yaa mutation results in expression of double the
levels of TLR7 that drives the B6.Sle1.Yaa mice to produce high titers of IgG
autoantibodies to RNA-associated autoantigens and increased numbers of
activated T cells, mononuclear neutrophils and monocytes (Marshak-Rothstein
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and Rifkin, 2007). In several lupus prone mouse models, deficiency of MyD88
abrogates the disease. One of the examples is an SLE mouse model that involves a
single mutation of the protein tyrosine Lyn gene (a negative regulator of BCR
signaling). In this model, disrupting the MyD88 signaling completely abolished
the IgG autoantibodies to nuclear antigens along with prevention of splenomegaly
and glomerulonephritis. A reduction in these mice serum antibody titers of IgM
and IgG2a similar to those of the wild-type mice, was reported with decreased
expression of maturation markers in dendritic cells and CD4+ T cell populations
when compared to the Lyn-/- mice (Silver et al., 2007). Teichmann and colleagues,
established the role of MyD88 in B cells but not in DCs in the progression of
lupus using the MRL.Faslpr model. Moreover, the frequency of follicular T helper
cells as well as IFN-γ producing CD4+ T cells were substantially reduced in
MyD88 deficient B cell and DCs in the lupus mice (Teichmann et al., 2013).
Other biologically active autoantigens include heat shock proteins (hsp),
glucosaminoglycans, high mobility group box 1 (HMGB1) and others. In one
study generation of hsp, gp96 cell surface expressing transgenic mice develop
hyper functional and over activated DCs in a MyD88 dependent manner leading to
spontaneous development of SLE like autoimmune disease (Liu et al., 2003).
Antibodies to Hsp60 and Hsp90 are commonly present in patients with SLE. High
mobility group box1 is a DNA binding protein that facilitates transcription and its
exposure to neutrophils/macrophages leads to increased production of
inflammatory cytokines through increased nuclear translocation of NF-ƘB.
HMGB induced activation of the myeloid cells has been demonstrated to involve
the interaction with TLR2 and TLR4 that generates inflammatory responses (Park
et al., 2004).
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In other autoimmune models such as autoimmune myocarditis, depletion of
C3 leads to reduced production of IL-1 and TNF-α and prevents the development
of the disease. The same model revealed a subset of CD44high CD62Llow
expressing complement receptors (CR1 and CR2), that are involved in the
activation of T cells through the upregulation of costimulatory molecules,
highlighting the role of complement pathway in the induction of myocarditis
(Zouali et al., 2005). In EAE mice models, complete resistance to the disease was
observed in MyD88-/- mice along with absence of proinflammatory cytokines and
hence, no brain inflammation. Though TLR2 is dispensable for induction of EAE,
absence of TLR4 aggravated the disease (Marta, 2009). Moreover, TLR4 and
TLR9 have a regulatory role in this Th17 mediated autoimmune disease where
TLR4-/- and TLR9-/- mice possess increased expression of IL-6 and IL-23, whereas
absence of MyD88 exhibited reduced levels of these cytokines along with IL-17
(Marta et al., 2008). Several in vitro and emerging in vivo research have
highlighted the role of TLRs in disease progression and appropriate manipulation
of these components in the treatment of chronic inflammatory conditions.
1.3. TLRs and their role in microbial infections
TLRs can bind to multiple components of bacterial cell wall such as
recognition of LPS of Gram-negative bacteria by TLR4, peptidoglycan from
Gram-positive bacteria (detected by TLR2), lipoarabinomannan (LAM) from
mycobacteria (detected by TLR2), diacyl or triacyl lipopeptides from bacteria,
mycobacteria and mycoplasma (detected by TLR2/1 or TLR2/6), flagellin from
flagellated bacteria (detected by TLR5) and genomic DNA rich in unmethylated
CpG DNA (detected by TLR9) from bacteria (Kumar et al., 2009). Ligand binding
leads to activation of antigen presenting macrophages and DCs that can recognize
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these ligands through the TLRs. This also directs their maturation to professional
APCs which initiates the adaptive immune response.
TLR2 plays a potent role in detecting Gram-positive bacterial components
particularly peptidoglycans and lipoproteins that are potent immunostimulants.
Infections with Staphylococcus aureus or Streptococcus pneumoniae caused
increased morbidity in TLR2-/- mice (Takeuchi et al., 1999); (Echchannaoui et al.,
2002). TLR2 reportedly has also shown to detect LPS in non enterobacteria such
as Porphyromonas gingivalis and Helicobacter pyroli but the LPS they detect is
structurally different from the typical LPS of Gram-negative bacteria (Hirschfeld
et al., 2001); (Smith et al., 2003). TLR2 identifies a large range of microbial
components as they form heterophilic dimers with other structurally related TLRs
like TLR1/ TLR6. Impaired TLR2 function in murine macrophages using gene
knockouts or antibody blocking, on exposure to the bacterial cell wall components
lead to diminished production of TNF-α and IL-6, in comparison to the normal
cells (Takeuchi et al., 1999); (Takeuchi et al., 2000); (Torres et al., 2004). Thus
several studies have demonstrated that TLR2-MyD88 dependent signaling
contribute significantly to host resistance.
LPS endotoxin, a major constituent of the outer wall of Gram-negative
bacteria interacts with CD14 (a soluble protein) and MD-2 (myeloid
differentiating factor 2) to bind to TLR4 and activates signaling through MyD88,
inducing a strong inflammatory response. TLR4 mutations have found to be
associated with hyporesponsiveness to LPS (Hoshino et al., 1999). TLR4 mutant
mice (C3H/HeJ mice) were highly susceptible to Mycobacterium tuberculosis
infection due to impaired macrophage recruitment and proinflammatory cytokine
response, leading to chronic infection of the bacteria (Abel et al., 2002). Impaired
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phagosome maturation has been observed in the absence of signaling through
MyD88 or TLR2/4 (Blander and Medzhitov, 2004). Infection with Candida
albicans in TLR4 null mice exhibited reduced macrophage inflammatory protein2 (Mip-2) and chemokine secretion (Netea et al., 2002). Moreover, a vast number
of gene expression in the lung as a result of Klebsiella pneumonia infection, is
controlled by TLR signaling that provides host survival (Schurr et al., 2005). On
the other hand, in response to LPS, MyD88 independent pathway has been found
to be activated in MyD88 deficient cells. These cells activate IRF3 which induce
production of IFN inducible genes. However, MyD88 dependent pathway is
crucial for the production of inflammatory cytokines to LPS through TLR4
signaling (Kawai et al., 2001).
Other TLRs, like TLR9 in co-operation with TLR2 have been found to
provide effective resistance to M. tuberculosis infection, with inflammatory
cytokine responses (IL-12p40, TNF, and IFN-α) and IFN-γ production (by CD4+
T cells) to be largely TLR9 dependent (Bafica et al., 2005). NF-ƘB activation and
chemokine gene expression to Helicobacter pyroli infection requires expression of
TLR2 and TLR5 (Smith et al., 2003). In some infections like Borrelia
burgdorferi, MyD88 signaling is critical for control of pathogen burden (Liu et al.,
2004). Control of intracellular bacteria like Brucella, is also largely dependent on
MyD88 for efficient pro-inflammatory cytokine production like TNF-α and
IL-12p40 from DCs. This adaptor molecule is also crucial for DC maturation and
activation that is essential for IFN-γ production by antigen specific T cells
(Macedo et al., 2008). In Chlamydial muridarum infection, reduction in IFN-γ
levels in natural killer cells has been associated with reduced inflammatory
cytokines, as a result of lack of MyD88 (Nagarajan et al., 2011). Several in vitro
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studies and in vivo studies have demonstrated the function of TLRs in recognition
of Salmonella PAMPs and their response through the induction of proinflammatory cytokine gene expression. Previously, we have confirmed the role of
signaling through TLRs in the survival of MyD88 deficient mice to both oral and
intraperitoneal infection with an attenuated strain of Salmonella Typhimurium
(Issac et al., 2013).
1.4. Salmonella infection
Salmonella of the family enterobacteriaceae are Gram-negative, flagellated,
rod shaped, facultative intracellular bacteria first discovered in 1885 in pigs.
About 2500 strains of the bacteria have been identified, most of which are
pathogenic. The bacilli vary depending on their capsular antigen, flagellar
antigens or envelope antigens. Salmonella species cause typhoid fever and
gastroenteritis in humans and front a worldwide threat to human health.
S. choleraesuis is associated with bacteremia, S. typhi and S. paratyphi which
produce enteric fever and S. Typhimurium and S. entiriditis which produce
gastroenteritis. Typhoid fever is the best studied enteric fever caused by S. typhi.
S. typhi infects approximately 20 million people per year and is responsible for
about 200,000 deaths per year (Broz et al., 2011). Infection is characterized by
fever, abdominal pain and diarrhea within 6-72 hours that continues up to a week.
Salmonella enteric species are generally contracted through contaminated poultry
food or fruits and vegetables. With the increasing number of Salmonella strains,
an emerging concern is their resistance to multiple antibiotics used to control or
prevent it. So far multi-drug resistant Salmonella strains have been found to be
resistant to fluroquinolones and third generation cephalosporins (World health
organization 10-14). Infection of Salmonella enterica serotype Typhimurium in
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mice results in a disease that resembles human enteric fever disease and is a
widely used model for the study of systemic Salmonella infection in humans.
The first stage of the infection which lasts for a few hours, involves rapid
clearance of the bacteria from the blood by phagocytic cells of the spleen and
liver, where large number of organisms are killed due to the bactericidal activity
of macrophages. In the second phase of infection, bacteria that have survived
undergo intracellular multiplication in the target organs and an exponential growth
phase occurs which is characterized by the production of inflammatory cytokines
like TNFα and IFN-γ that is vital for the induction of macrophage bactericidal
activity to suppress infection (Mittrucker and Kaufmann, 2000); (Sebastiani et al.,
2002). The host is then able to curb the bacterial growth and reach a plateau phase
with high bacteria levels. Once the acquired immunity involving both B cells and
T cells develop, particularly the activation and expansion of Th1 cells the bacterial
infection is efficiently cleared. The main route of entry is through specialized
epithelial cells of the Peyer’s patches called M cells. Salmonella then further
propagates to the mesenteric lymph nodes and eventually through the blood
stream to the spleen and liver causing disease. In the initial stages of bacterial
infection after ingestion of contaminated food, bacteria adhere and cause
subsequent invasion in the intestine. Bacterial adherence is mediated through
type1 and type IV fimbriae, autotransporter adhesins as well as type 1 repetitive
adhesins (Linke et al., 2011). Salmonella gain access into the macrophages
through phagocytosis and receptor mediated uptake. Alongside, the injection of
the secretory proteins by the bacteria enhances uptake and drives internalization
(Finlay and Brumell, 2000). Virulence proteins called type3 secretion system
(T3SS) encoded by Salmonella pathogenicity island (SPI) promote bacterial
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uptake into the host cells and its survival. T3SS coded by SPI-1 in the intestinal
lumen is involved in bacterial invasion into the epithelial cells and host cells,
while T3SS encoded by SPI-2 is involved in the systemic phase of intracellular
bacterial replication and survival as well as dissemination to the organs (Salcedo
et al., 2001). Proteins coded by SPI-2 inhibit the fusion of Salmonella containing
vacuoles in the macrophages with the lysosomes and endosomes (Uchiya et al.,
1999); (Tobar et al., 2006). This is facilitated by the ability of the SPI-2 TSS to
thwart the NADPH oxidase assembly at the phagosomal membrane thus evading
oxidative damage (Gallois et al., 2001). The effector proteins also counteract the
localization of iNOS to the Salmonella containing vacuole thus, avoiding death by
the combined microbicidal effect of reactive oxygen and nitrogen species
(Chakravortty et al., 2002). The induction of these proteins plays a vital role in
determining the virulence of Salmonella and its systemic spread into the host
tissues.
Several mouse strains vary in their susceptibility to Salmonella infection
depending upon their status of their Nramp1 (natural resistance-associated
macrophage protein 1) gene expression. This macrophage specific transmembrane
protein acts as a channel for divalent cations into the phagosome and controls
intracellular microbial replication during the early phase of infection. A wild-type
allele of the gene is present in the mouse strains of C3H and 129, while C57BL/6
and BALB/c carry a mutant allele of the gene making them 1000 fold more
susceptible to Salmonella infection (al-Ramadi et al., 2001); (al-Ramadi et al.,
2002); (al-Ramadi et al., 2004); (Gerold et al., 2007). The Nramp1 gene provides
natural resistance to several intracellular infections and any mutation in the gene
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reduces the efficacy to kill the pathogen and thus has been associated with
increased susceptibility (Skamene et al., 1998).
1.5. Role of TLRs in Salmonella infections and its association with
autoimmunity
The main ligands of Salmonella that recognize and activate TLRs are the
lipopolysaccharide, lipoproteins, CpG DNA and flagellin which are recognized
by TLR4, TLR2, TLR9 and TLR5 respectively (Hoshino et al., 1999); (Gewirtz et
al., 2001); (Feuillet et al., 2006); (O'Brien et al., 1980); (Vazquez-Torres et al.,
2004). Csg component of the fimbriae that forms a structural characteristic of
Salmonella Typhimurium is recognized by TLR2, eliciting an IL-8 host immune
response (Tukel et al., 2005). LPS was postulated to being the major virulence
factor since direct injection of LPS into the blood stream caused shock. Endotoxin
containing LPS and BLP of Gram-negative bacteria can induce a strong
inflammatory response. TLR4 responds to LPS-binding protein in association with
CD14 and MD-2 proteins (Vazquez-Torres et al., 2004). A dominant missense
mutation in TLR4 signaling in C3H/HeJ strain leads to impaired production of
TNF-α, a cytokine that is crucial for protective function in response to Salmonella
infection, when compared to wild-type mice (Li and Cherayil, 2003). TLR4-/- mice
were more susceptible to infection than TLR2-/- mice which were similar to the
WT mice, suggesting that TLR4 seems to a dominant role over TLR2, mainly due
to its earlier expression in the immune response to Salmonella. However, MyD88/-

mice harbored the most bacterial burden due to defective macrophage killing and

TNF-α production (Weiss et al., 2004). Moreover, TLR4 signaling through
MyD88 and not TRIF, is essential for protection by establishing a plateau phase of
bacterial growth in the typhoid model, as negligible levels of NO and TNF-α
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production were observed in MyD88-/- mice (Talbot et al., 2009). Activation of
TLR9 enhances the antigen presentation by DCs and killing of Salmonella
organisms in a ROS dependent manner (Lahiri et al., 2010). Furthermore,
interaction of TLR5 of the lamina propria DCs with the Salmonella organisms,
mediate migration of the bacteria across intestinal mucosa to the mesenteric
lymph nodes (Uematsu et al., 2006). On the other hand, TLR11 blocks the entry of
highly invasive Salmonella into the murine Peyer’s patch and the systemic spread,
highlighting the potential of TLR11-/- mice as S. Typhimurium murine model (Shi
et al., 2012). Interestingly, a study has also shown that S. Typhimurium failed to
form Salmonella containing vacuole and multiply in TLR2/4/9-/- and MyD88-/bone marrow derived macrophages, suggesting a pre-requisite of TLR signaling in
the induction of virulent gene expression for bacterial survival (Arpaia et al.,
2011b). Furthermore, inflammation in Salmonella colitis as a result of induction
of T3SS by SPI-2, is solely dependent on MyD88 signaling while SPI-1 induced
T3SS causes inflammation in a MyD88 independent manner (Hapfelmeier et al.,
2005).
MyD88 as an adaptor molecule, plays a crucial role in the acute phase of
infection as MyD88-/- mice are hyper-susceptible to even an infection with an
attenuated strain of S. Typhimurium, due to increased bacterial burden in target
organs, delayed recruitment of phagocytes and production of inflammatory
cytokines (Issac et al., 2013). Several studies have confirmed the generation of
antibody responses to S. Typhimurium, even in TLR mutant mice strains.
Generally, Salmonella infection in wild-type mice is characterized by a Th1
mediated IFN-γ response that drives B cells to the production of IgG3 and IgG2c
humoral response. However, enhanced Salmonella specific IgG1 responses were
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found to take place independently of signaling through MyD88 and TLR4 (Seibert
et al., 2010). This was confirmed in another study where oral infection with
recombinant attenuated S. Typhimurium (RASV) elicited dominant Th2 responses
in MyD88-/- mice, suggesting that signaling through the adaptor molecule may be
dispensable for induction of LPS specific antibody responses (Ko et al., 2009).
Moreover, in our previous study we verified dysregulated Salmonella specific
antibody responses of all isotypes (both Th1 and Th2 responses) being produced
in the MyD88 deficient mice in response to intraperitoneal infection of
Salmonella, establishing a state of hypergammaglobulinemia. The memory T cells
produced as a result of the bacterial dose, however failed to protect the MyD88
knockout mice on a challenge to the virulent strain of the bacteria, further
emphasizing the vitality of efficient signaling through the MyD88 for protection
against Salmonella infection (Issac et al., 2013).
Several studies, as briefly described earlier, have confirmed TLRs to be
actively involved in the pathogenesis of autoimmune diseases. Irrespective of the
specificity of B cell receptor, TLR expression in B cells activates autoreactive B
cells in autoantibody production (Soulas et al., 2005). A dramatic IgM
hypergammaglobulinemia response, as a result of B cell hyper activation was
observed in MyD88-/- mice, in response to Borrelia burgdorferi infection. This
contributed to autoreactivity of IgM antibodies to autoantigens at levels similar to
those observed in a lupus prone MRL/lpr mouse strain (Woods et al., 2008).
Similarly, oral administration of RASV in MyD88-/- mice induces hyper-IgG
autoimmune response in a T cell dependent manner, involving increased dsDNA
autoantibody levels along with deposition of immune complex in the kidneys.
Oral infection also leads to systemic inflammation characterized by increased

39

levels of inflammatory cytokines from enhanced inflammatory myeloid cell
populations along with expansion of the B cell and T cell compartment
compartment (Ko et al., 2011).
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2. AIMS OF THE THESIS
The overall aims of the thesis were to understand the potential mechanism
involved in the observed phenomenon of hypergammaglobulinemia and to test the
loss of immunological self-tolerance in MyD88-deficient mice following infection
with Salmonella Typhimurium.
The specific aims were:
1. To define the underlying mechanisms involved in the induction of
hypergammaglobulinemia in mice lacking MyD88 following infection with
attenuated S. Typhimurium.
2. To characterize the extent and specificities of autoantibody production in
Salmonella-infected MyD88-/- mice and define the parameters required for
their synthesis.
3. To uncover the cellular and molecular mechanisms responsible for the
dysregulated antibody production.
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3. MATERIALS AND METHODS
3.1. Materials
3.1.1. Summary of materials used and suppliers:
Materials

Company

PBS (-CaCl2 – MgCl2)

GIBCO

10X PBS (-CaCl2 – MgCl2)

GIBCO

BSA

Sigma

SS Agar

Mast Group

Trypticase soy agar

Mast Group

Trypticase soy broth

Oxoid

RPMI 1640 medium (-L glutamine)

HyClone

Ethanol

Carlo Erba

H2SO4

Readel-de Haen

Tryptan blue solution (0.4%)

Sigma

DPX

Panreac

Ampicillin

Sigma

Streptomycin

Sigma

NaCl

Panreac

NaH2PO4. H2O

Panreac

Na2HPO4

Panreac

Na2CO3

AnalaR

NaN3

AnalaR

NaHCO3

GibcoBRL
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NH4CL

Sigma

KHCO3

Sigma

EDTA

Sigma

H3BO3

Sigma

96 well Maxisorp nunc immuno plate

Thermo Scientific

24 well tissue culture plates

Becton Dickenson

96 well Microtest U bottom culture plates

Becton Dickenson

Microscope slides

Fischer Scientific

7-AAD Viability Staining Solution

e-Bioscience

Streptavidin HRP

R&D

TMB

Becton Dickenson

Xylene

Panreac

Heamotoxylin

Panreac

3.1.2. Standard solutions
3.1.2.1. 10x Phosphate buffered saline (PBS) for antibody determination by
ELISA
87.66 g of NaCl, 2.56g of NaH2PO4, 11.94g of Na2HPO4 dissolved in 1L d.H2O,
pH 7.2.
3.1.2.2. Phosphate buffered saline (PBS) with 0.05% Tween-20
1x PBS (made from home-made 10xPBS) with 0.05% tween-20, pH 7.2- 7.4
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3.1.2.3. Trypticase soy broth (TSB)
3.1.2.4. RBC lysis buffer
8.3NH4Cl, 1g KHCO3 1.3ml of 5%EDTA dissolved in 1L distilled water and
filtered through 0.2µm filter
3.1.2.5. Blocking buffer for pathogen specific antibody detection by ELISA
(1% BSA, 5% sucrose, 0.05% NaN3 in PBS)
5g of BSA, 25g of sucrose, 0.25g NaN3 in 500ml 1xPBS (made from home-made
10xPBS), pH 7.2-7.4
3.1.2.6. Reagent diluent for antibody determination ELISA (1%BSA)
1g Bovine serum Albumin dissolved in 100ml 1xPBS (made from home-made
10xPBS), pH 7.2-7.4
3.1.2.7. 0.05M Carbonate Buffer for autoantibodies detection by ELISA
0.16g Na2CO3 and 0.3g NaHCO3 dissolved in 100ml PBS, pH 9.6
3.1.2.8. Borate buffer saline (BBS)
200mM of boric acid, 75mM NaCl in 1L d.H20, pH 8.4
3.1.2.9. BBT
0.5%BSA, 0.4%tween in BBS
3.1.2.10. BBS: BBT
0.5%BSA, 0.1% NaN3 and 0.4%tween in BBS
3.1.2.11. 2N H2SO4
6ml of conc.H2SO4 was dissolved in 100ml d.H20
3.1.2.12. Staining Buffer for FACS (PBS/1% FCS/0.1% NaN3)
1ml Fetal calf serum and 0.1g NaN3 was dissolved in 100ml PBS
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3.1.2.13. 4% paraformaldehyde for fixation
100ml 37% formaldehyde in 400ml d.H2O and 500ml 0.2M Phosphate buffer
3.1.2.14. AutoMACS buffer for cell purification
0.5% BSA, 2mM EDTA in 1xPBS, pH 7.2
3.1.3. List of antibodies used in ELISA and cell culture:
Antibody

Catalogue
#

Company

Concentration
/ Dilution used

Rat anti-mouse IgG3 (Biotin) 1191-08

Southern Biotech

1:5000

Goat anti-mouse IgG1
(Biotin)
Goat anti-mouse IgG2c
(Biotin)
Goat anti-mouse IgM
(Biotin)

1070-08

Southern Biotech

1:20,000

1079-08

Southern Biotech

1:20,000

115-066075

Jackson
Immunoresearch

1:10,000

Purified mouse IgG1

0102-01

Southern Biotech

50ng/ml

Purified mouse IgG2c

0122-01

Southern Biotech

50ng/ml

Goat anti-mouse
1010-01
IgM+IgG+IgA (H+L)
Goat anti-mouse IgG, F(ab´)2 115-006fragment-specific
006

Southern Biotech

0.1µg/ml

Jackson
Immunoresearch

1µg/ml

Biotin labeled-goat antimouse IgG (Fc-specific)

115-066008

Jackson
Immunoresearch

1:10,000

FITC-labeled goat antimouse IgG (Fc-specific)
Purified anti-mouse CD3
(clone 2C11)
Hamster anti-mouse CD28
(clone 37.N.51)

31547

Pierce

1:100

8310

CJ Lab

1-5µg/ml

12.96

CJ Lab

10-20µg/ml

Mouse IgG

115-000003

Jackson
Immunoresearch

1µg/ml

Mouse IFN-γ set

555138

Mouse IL-4 set

555232

Mouse IL-10 set

555252

Becton
Dickenson
Becton
Dickenson
Becton
Dickenson
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3.1.4. Antibodies used for FACS staining
Antibody

Conjugate

Company

Catalogue Dilution
used

Rat anti-mouse CD3

FITC

BDPharmingen 553063

1:200

Rat anti-mouse CD4

PE-Cy7

Biolegend

100528

1:200

Rat anti-mouse CD4

APC-Cy7

BDPharmingen 552051

1:100

Rat anti-mouse CD4

APC

e-Bioscience

Rat anti-mouse CD8a

APC-Cy7

BDPharmingen 557654

Rat anti-mouse CD11b

e-Bioscience

Rat anti-mouse CD19

APCeFluor780
PE-Cy7

BDPharmingen 552854

1:200

Rat anti-mouse Sca-1

PE

BDPharmingen 553336

1:100

Rat anti-mouse Ly6G/C

FITC

e-Bioscience

17004182 1:200

47011282 1:500

11593182 1:200

Hamster
anti-mouse APC
CD80
Rat anti-mouse CD86
FITC

BDPharmingen 560016

anti-mouse CD25

BDPharmingen 557192

APC

e-Bioscience

1:100

1:200

11086282 1:100
1:100

Armenian Hamster IgG1 Alexa Fluor e-Bioscience
Isotype Control
488

12488883 1:200

Rat
IgG2a
Control
Rat
IgG2a
Control
Rat
IgG2a
Control
Rat
IgG2b
Control
Rat
IgG2b
Control
Rat
IgG2b
Control

Isotype PE-Cy7

e-Bioscience

25432182 1:200

Isotype PE

e-Bioscience

12432182 1:200

Isotype APCeFluor780
Isotype FITC

e-Bioscience

47432182 1:200

e-Bioscience

11403182 1:200

Isotype APC

e-Bioscience

17403182 1:200

Isotype APCeFluor780

e-Bioscience

47403182 1:200
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Rat
IgG2a
Isotype
Control
Rat
IgG1
Isotype
Control
Rat anti-mouse IFN-γ
(for
intracellular
staining)
Rat anti-mouse IL-4
(for
intracellular
staining)
Rat anti-mouse IL-10
(for
intracellular
staining)
Rat
IgG1
Isotype
Control
Rat
IgG2b
Isotype
Control
Anti-mouse CD16/32

FITC

e-Bioscience

11432182 1:200

APC

Biolegend

400412

1:200

PE-Cy7

Biolegend

505826

1:100

APC

Biolegend

504106

1:100

PE

Biolegend

505008

1:100

PE-Cy7

Biolegend

400416

1:200

PE

Biolegend

400608

1:200

-

e-Bioscience

14016185 1:100

3.1.5. Mice
C57BL/6 mice, obtained from Harlan Olac (Bicester U.K.) and MyD88deficient (MyD88-/-) mice provided by Dr. S. Akira (Osaka University, Japan)
(Adachi et al., 1998a; Kawai et al., 1999) through Dr. Richard Flavell (Yale
University School of Medicine, USA) were bred in our animal facility and
maintained in filter-topped isolator cages on Bactrim-supplemented water (for
MyD88-/- mice only). CD154-/- mice (CD40L-/-) mice on C57BL/6 background
were provided by Dr Richard Flavell’s lab (al-Ramadi et al., 2006); (Xu et al.,
1998). Mice were taken off antibiotics for at least 7-10 days before use in any
experiment. All animals were routinely used at 8-12 weeks of age. All studies
involving animals were conducted in accordance with and after approval of the
animal research ethics committee of the College of Medicine and Health Sciences,
United Arab Emirates University.
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3.2. Methods
3.2.1. Bacterial strains used and preparation
For the current studies, we used an attenuated, double auxotrophic, strain of
Salmonella enterica serovar Typhimurium (hereafter referred to as S.
Typhimurium), with deletions in the aroA and aroD genes which are critical for
the synthesis of essential prokaryotic aromatic compounds. The aroA-/aroDmutant strain, designated BRD509, expressing the empty nirB plasmid vector was
used throughout (al-Ramadi et al., 2001); (al-Ramadi et al., 2004). It acquired
resistance to ampicillin, which is encoded by the nirB plasmid, and can therefore
be easily selected. IFN-γ and IL-2 cytokine expressing strains of BRD509,
designated GIDIFN and GIDIL2, have been previously described (Al-Ojali et al.,
2012a); (al-Ramadi et al., 2002); (al-Ramadi et al., 2001). The expression of IFNγ and IL-2 is under the control of the nirB promoter (Xu et al., 1998). In some
studies, we also utilized a strain of Acinetobacter baumanii (designated NM97),
which is a clinical isolate from Tawam hospital, and was kindly provided by Dr.
Tibor Pal (Department of Microbiology & Immunology, CMHS). Aliquots of
BRD509 (or its derivative strains) were grown on Salmonella Shigella (SS) agar
[with ampicillin (100g/ml conc.)]. A.baumanii (NM97) strain was grown on
trypticase soy agar (TSA). For the BRD509 (or its derivative strains) bacterial
dosage preparation, about 4-5 CFUs were cultured in 10 ml trypticase soy broth
(TSB) containing ampicillin (1µg/ml) overnight and then diluted 1:10 in fresh
TSB [with ampicillin (1µg/ml)] and grown for 2 hours (shaking) at 37°C. At the
end of this incubation, the OD600 nm optical density of the bacterial suspension
was measured at 600nm. 1ml of the culture was read on a spectrophotometer
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against TSB as blank. The bacterial concentration was estimated based on the
formula of OD600 nm of 1=1.2x109/ml bacterial CFUs. Log-phase bacterial
suspensions were prepared in pyrogen-free saline and injected intraperitonealy
(i.p) in 0.5ml volume at the indicated dose. For the NM97 bacterial dosage
preparation, about 4-5 CFUs were cultured in 5ml TSB overnight. The next day, 5
ml bacterial culture was poured into a conical flask containing 45ml fresh TSB
and kept for shaking at 37°C for 4 hours. The bacterial culture was then
transferred to a 50 ml tube, centrifuged at 3500 rpm for 15 minutes and resuspended in 1xPBS. The culture at 1:100 dilution was read on a
spectrophotometer against 1xPBS as blank. Log-phase bacterial suspensions were
prepared in pyrogen-free saline and injected intraperitonealy in 0.5 ml volume at
the indicated dose. For all infections, the bacterial doses were verified by CFU
plate counts.
3.2.2. Enumeration of bacterial load and IgA extraction from fecal pellets
Procedures for determination of CFU have been described previously (alRamadi et al., 2001). Groups of mice (5-10 mice per group) were sacrificed at
different time points after i.p infection. Feces were freshly collected, weighed and
suspended in 1xPBS. The suspension was vortexed and an aliquot at an
appropriate dilution was streaked on SS agar plate containing both ampicillin
(100g/ml) and streptomycin (200g/ml) and the CFU counts were determined
after overnight incubation at 37°C. To determine the bacterial loads in spleen and
liver, target organs were aseptically removed at the indicated time points and
homogenized in 1 ml of cold sterile saline in an Ultra-terrax T25 tissue
homogenizer (Janke & Kunkle, Staufenim Breisgau, Germany). An aliquot of
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appropriate dilution was streaked on SS agar (with ampicillin) plates for BRD509
and the CFU counts were determined after overnight incubation at 37°C. Spleen
weights were also determined at the indicated time points post inoculation.
For secretory IgA extraction, fecal pellets were suspended at a concentration
of 250 mg/ml of cold extraction buffer consisting of 1×PBS solution, 30 mM
EDTA, 1% BSA, and 1/100 dilution of protease inhibitor cocktail stock
(Calbiochem, Germany). The suspension was then vortexed and supernatants were
collected after centrifugation at 10,000 rpm for 7 minutes at 4oC and stored at
−20oC until assayed for IgA levels.
3.2.3. Peritoneal exudate cell collection
Groups of mice (5–10 mice per group) were sacrificed at different time
points after infection. To harvest peritoneal lavage, 10 ml of cold Ca2+-, Mg2+free saline was injected into the exposed peritoneal cavity and the fluid was
withdrawn through the anterior abdominal wall with a 20-gauge needle. The fluid
was then spun down at 2500 × g for 5 minutes and the cell pellet was resuspended
in distilled water.
3.2.4. Spleen cell preparation
Single cell suspensions were prepared by gently teasing the spleen between
frosted ends of microscope slides. Cells were then spun down at 1200 rpm for 5
minutes at 4°C. The spleen cell suspension was depleted of red blood cells by
incubation in RBC Lysis buffer (10-12 ml/spleen sample) for 5 minutes, after
which they were spun down at 1200 rpm for 5 minutes and suspended in 1xPBS.
The erythrocyte-depleted spleen cells were counted on a hemocytometer and cell
viability was determined by trypan blue dye exclusion.
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3.2.5. Spleen cell purification
Purification of CD4+ and CD11b+ spleen cell subpopulations was done using
magnetic bead separation on an autoMACS cell sorter (Miltenyi Biotec,
Germany), following manufacturer’s procedure. For the purification of T
lymphocytes, spleen cells (10 x 106 cells per run) were centrifuged at 300 x g for
10 minutes and cell pellets were re-suspended in 90µl of autoMACS buffer and
10µl of anti-CD4 mAb-coated magnetic beads (GK 1.5 clone, Miltenyl Biotec). In
case a higher cell number was needed for purification, the volume of buffer and
magnetic beads were adjusted accordingly, while maintaining the cell: magnetic
beads ratio. After incubation with mAb-coated magnetic beads for 15 minutes at
4-8°C, spleen cells were washed with 1ml of buffer and centrifuged again at 300 x
g for 10 minutes. Cells were then re-suspended in 500µl buffer and CD4-positive
cell fraction was collected using the Possel program on the autoMACS cell sorter.
The extent of cell purity was verified independently by staining with non-crossreactive CD4-specific mAb (RM 4-5) and analysis on a FACSCanto (BD).
Routinely, purified cells were confirmed to be 90-95% CD4+ T cells.
The CD4+ T cell-negative fraction of the spleen cell suspension was also
collected, and cell number was determined, for subsequent purification of CD11b+
myeloid cells. For this purification, 10 x 106 spleen cells were re-suspended in
90µl of autoMACS buffer and incubated with 10µl of anti-CD11b mAb-coated
magnetic beads (Miltenyl Biotec) for 15 minutes at 4-8°C. After incubation, the
cells were washed with 1ml of the buffer and centrifuged again at 300 x g for 10
minutes. Cells were then re-suspended in 500µl buffer and magnetic separation
was carried out with the autoMACS separator. CD11b-positive cell fraction was
collected using the Possel program on the magnetic cell sorter. Routinely, the cells
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collected were composed of 75-85% CD11b+ cells as confirmed by staining with
fluorochrome conjugated anti-CD11b antibodies.
3.2.6. Flow cytometry
Spleen cell suspensions were prepared from animals infected intraperitonealy
21 days previously with a dose of about 3000 BRD509/mouse. Processing of
spleen cells for FACS analysis was conducted, as described previously (al-Ramadi
et al., 2001). Whole spleen cells and PECs obtained from the peritoneal wash, as
described above were re-suspended in staining buffer (SB) (PBS/1% FCS/0.1%
NaN3) at a concentration of 0.5 x 106 cells/well in U-bottom 96-well plate (BD)
and incubated with 50µl/well of anti-mouse CD16/CD32-specific mAb (clone
2.4G2) for 30 minutes at 4°C to block FcγRΙΙΙ/ΙΙ sites in order to avoid
nonspecific binding. The plate was then centrifuged at 750 rpm for 3 minutes at
4°C. After decanting the buffer, cells were stained with appropriate dilutions, of
directly-conjugated

monoclonal

antibodies

(mAbs;

all

purchased

from eBioscience or BD or BioLegend, as previously mentioned and detailed in
Table 3.1.4) in a total volume of 100µl/well and analyzed by 6-color FACS. In all
staining groups, 7-AAD dye (e-Bioscience) was included in order to exclude nonviable cells from the analysis. All antibodies were pre-titrated in preliminary
experiments and used at saturating concentrations. Cells were incubated with a
mixture of appropriately-diluted mAbs at 4°C for 30 minutes followed by two
wash cycles with SB. The first wash was with 100 µl/well of SB where the cells
were mixed well with the pipette and centrifuged. In the second wash, 200 µl/well
of SB was added and mixed well followed by centrifugation. Cells were finally resuspended in 200µl/well of SB and fixed by adding 100µl of 4%
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paraformaldehyde per well. Data were collected on 30,000 cells using BD
FACSCantoII and analyzed using BD FACSDiva software.
For intracellular cytokine staining, 100µl of anti-mouse CD3 (clone 2C11) at
5µg/well and 100µl of anti-mouse CD28 (clone 37.N.51) at 20µg/well in 1xPBS
were added into 24-well tissue culture plates and incubated at 37°C with 5% CO2
for 2 hours after which the solution was aspirated from each well. Enriched CD4+
T cells (1 x 106 cells/ml/well) were suspended in RPMI supplemented with
5%FCS, l-glutamine, sodium pyruvate, essential amino acids, non-essential amino
acids, pen/strep, gentamicin, and 2-ME (all reagents from Gibco BRL) for
stimulation at 37°C with 5%CO2 for 24 hours. Purified CD4+ T cells incubated in
the absence of anti-CD3/CD28 mAb were also included and used as nonstimulated control. Four hours before harvesting the cells, 1 µl of BD GolgiPlug
(Brefeldin A) was added per well. Intracellular staining for cytokines was carried
out following staining for cell surface antigens as described earlier, after which
cells

were

permeabilized

using

permeabilization/fixation

buffer

(BD

Cytofix/Cytoperm Plus #555028) for 20 minutes at 4°C. Cells were then incubated
with 100µl/well of antibody conjugates of IFN-, IL-4 or IL-10 for 30 minutes at
4°C and washed with 1x Perm/Wash solution. Isotype controls for the respective
cell surface and intracellular antibodies were used to determine nonspecific
binding. Data were collected on 30,000 cells and analyzed using BD FACSDiva
software.
3.2.7. Preparation of heat killed bacteria
Bacterial strains were grown to log-phase, as described above. After taking
an aliqout for verification plate counting, bacterial suspension was washed in
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pyrogen-free saline, centrifuged at 4000 rpm for 15 minutes at 4°C and finally resuspended in 5 ml PBS. The samples were then placed in a water bath at 650C for
1 hour, following which aliquots (100µl) were removed and streaked on SS agar
or TSA plates for BRD509 or NM97 bacterial strains, respectively, to confirm that
all bacteria were heat killed. The remainder of the heat-treated suspension was
aliquoted in 0.5 ml volume and stored at -20°C until use.
3.2.8. Measurement of pathogen specific antibodies in serum
Serum samples were obtained at the indicated time points post i.p infection
with ~200 CFUs/mouse. Blood was collected on the day of sacrifice from the vena
cava, left at room temperature to clot for 30-60 minutes, spun down at 2500 rpm
for 5 minutes, following which sera (~200-300µl) were collected. Serum samples
were stored at -20°C till further analysis. The presence of Salmonella-specific as
well as Acinetobacter-specific antibodies of IgG1, IgG2b, IgG2c, IgG3, and IgM
isotypes were determined by an established ELISA protocol (Issac et al., 2013).
Maxisorp 96-well plates (Nunc, Roskilde, Denmark) were coated overnight with
100 µl/well of heat-killed bacteria (1 x 106 cells/well). Wells were then washed 3
times with PBS-T and blocked for 2 hours at room temperature using 300µl/well
of the blocking buffer (1%BSA, 5%Sucrose, 0.05%NaN3 in PBS). To generate a
standard curve, wells were coated with 0.1µg/ml of goat anti-mouse Ig(H+L)
(Southern Biotech), and blocked with 300µl/well of 2% BSA in 1xPBS (7.2 pH).
After one wash cycle, serum samples from individual animals were serially
titrated in the plate (range 1/100 to 1/3200 dilution, in duplicates). For the
standard wells, mouse isotype-specific antibody (Southern Biotech) (starting at
50ng/ml and titrated in 1:2 serial dilutions) was added in a final volume of
100µl/well. The standards were prepared in separate tubes and added in 100µl
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aliquots to appropriate wells. For the serum samples, dilutions were carried out
directly in the plate. The test plates were then incubated at room temperature for 2
hours. After extensive washing, secondary antibodies (biotin-conjugated, isotypespecific antibodies; dilutions indicated in table 3.1.3) were added (100µl/well) and
incubated for another 2 hours at room temperature. After another series of washes,
streptavidin–HRP (100µl/well; R&D #DY998) was added at a final dilution of
1/200 and incubated for 40 minutes. Wells were washed again and developed by
adding 100µl/well of the substrate 3,3′,5,5′-tetramethylbenzidine (TMB; Becton
Dickenson #555214) and incubated for 10-30 minutes. The reaction was stopped
by adding 50µl/well of 2N H2SO4. Plates were read at 450 nm using a TECAN
microplate reader (Maennedorf, Switzerland).
3.2.9. Total IgG isotypes
Nunc MaxiSorp 96-well plates were coated with 100µl of 1µg/ml goat antimouse IgG F(ab′)2 (Jackson Immunoresearch) in 0.5M sodium bicarbonate
(pH=9.6) and incubated at 4°C overnight. After washing, plates were blocked for
2 hours with 200µl/well of 3% BSA in 1xPBS (pH 7.2). Plates were washed and
serially diluted samples along with standard dilutions of mouse isotype specific
antibody (Southern Biotech) in 1% BSA were added at a final volume of
100µl/well. The standards were prepared in individual eppendorf tubes and 100µl
aliquots were transferred to the wells. For the test samples, serial dilutions were
carried out directly in the plate, followed by incubation for 2 hours at room
temperature. After a series of washes, 100µl of biotin-labeled goat anti-mouse IgG
(isotype specific) (Southern Biotech) antibody was added and incubated for an
additional 2 hours followed by streptavidin-HRP, as mentioned earlier. TMB
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substrate solution was added for color development and stopped with 2N H2SO4.
The plates were then read at 450nm using TECAN reader.
3.2.10. Cytokine determination
PECs obtained from the peritoneal wash, were also resuspended in
supplemented RPMI medium and kept at 4 ◦C until placed in tissue culture plates.
Cells were cultured, without further stimulation, at a concentration of 1.5 ×
106/ml (PECs) in 24-well plates and incubated for 24–48 hours at 37 ◦C with 5%
CO2. Culture supernatants were then collected, spun free of any cells, and kept at
−20 ◦C until assayed. Production of NO was measured by the accumulation of
NO2− in culture supernatants by the Griess reaction, following a procedure
previously published (al-Ramadi et al. 1992). Production of IL-6 and IL-12 was
quantitated in culture medium following in vitro culture of peritoneal, or spleen
cell population after 2, 24 or 48 hours of infection.
Spleen cells were stimulated by plate-bound mAbs specific to murine CD3
and CD28 molecules. For Ab immobilization, anti-mouse CD3 (clone: 2C11;
50µl/well; 1µg/well) and anti-mouse CD28 (clone 37.N.51; 50µl/well; 10µg/well)
mAbs were diluted in 1xPBS and added into 96-well U bottom plates (BD) and
incubated at 370C with 5% CO2 for 2 hours after which, the solution was aspirated
from each well. Purified CD4+ splenic T cells (1 x 105 cells/200µl), resuspended
in complete medium (RPMI + 5%FCS + supplements), were then added and
incubated at 37oC in a humidified incubator with 5% CO2 for 24 hours. As
controls, purified CD4+ T cells were incubated without anti-CD3/CD28 mAb
stimulation. Cells were spun down at 3,000 rpm for 7 minutes and supernatants
were collected. Cell-free culture supernatants were analyzed for IFN-, IL-4 and

56

IL-10 cytokines using specific ELISA kits from BD Biosciences (as mentioned in
table 3.1.3.) according to manufacturer’s instructions. For the IFN- ELISA, test
supernatants were run at final dilutions of 1:10-1:20. For IL-4 detection, all
samples were run undiluted. For IL-10 cytokine detection, test supernatants were
run either undiluted (for C57BL/6 group) or 1:2 dilution (for the infected
MyD88-/- groups). Test supernatants from all non-infected control groups were run
undiluted for all ELISA determinations.
3.2.11. Measurement of autoantibodies in serum
The production of autoantibodies specific to dsDNA, thyroglobulin and
mouse IgG (rheumatoid factor) was assessed by ELISA following a published
method with modification (Chen et al., 1998). For the detection of anti-dsDNA
antibodies, Maxisorp Nunc ELISA plates (Thermo Scientific) were coated with
dsDNA at a final concentration of 1µg/ml (from calf thymus; Sigma #D4522)
diluted in borate-buffered saline (BBS) and incubated overnight at 4°C. Following
3 washes with BBS, wells were blocked with 200µl/well of BBS supplemented
with Tween and BSA (BBT:BBS, 0.4%Tween 80, 0.5%BSA, and 0.1%NaN3) for
1 hour at room temperature. Serum samples diluted to 1/1000 in BBT were added
in duplicate, serially titrated on the plate (to a final volume of 100µl/well) and
incubated for 2 hours at room temperature. After washing with BBS, the plates
were incubated for 2 hours at room temperature with biotinylated goat anti mouse
IgG (Fc-specific; Jackson Immunoresearch), diluted 1/10,000 in BBT
(100µl/well). The plates were finally washed and incubated with streptavidin-HRP
and developed using TMB, as mentioned above. Reaction was stopped with 2N
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H2SO4 and read at 450 nm using a TECAN microplate reader (Maennedorf,
Switzerland).
For the detection of RF and anti-thyroglobulin antibodies, Maxisorp plates
were coated overnight at 4°C with 100µl of 1μg/ml of mouse IgG (Jackson
Immunoresearch Laboratories) for RF assay or 100µl of 1μg/ml of thyroglobulin
(from bovine thyroid; Sigma #T1001) diluted in 0.05M carbonate buffer
(pH=9.6). Following 3 washes with PBS containing 0.05% Tween (PBS-T; pH
=7.2), the plates were blocked with 200µl/well of 1% BSA in PBS-T at room
temperature for 2 hours. Serum samples, diluted to 1/1000 in PBS-T containing
0.5M NaCl, were added in duplicate, serially titrated on the plate (to a final
volume of 100µl/well) and incubated for 2 hours at room temperature. The plates
were then washed and developed using the same procedure described above.
3.2.12. Detection of ANA by immunoflurosence using HEp-2 cells.
Serum ANA antibodies were detected by indirect immunofluorescence using
HEp-2 ANA kit (INOVA Diagnostics, San Diego, CA, USA #708100), according
to the manufacturer's protocol.
Diluted serum samples (1/80 dilution) and controls were added (25µl per
reaction) and incubated for 30 minutes in a moist chamber at room temperature.
After a gentle rinse with PBS, the slides were washed by immersing in a tray filled
with PBS for 5 minutes. PBS was changed and the wash repeated. One drop of
goat anti-mouse IgG-FITC (Pierce) was added into each well and incubated for 30
minutes. Slides were washed similarly in PBS and dried, following which the
mounting media was added and coverslip placed. The fluorescence was visualized
at 400x magnification using an Olympus BX51fluorescence microscope (Olympus
Corporation, Japan)
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3.2.13. Histopathological kindney analysis.
Kidneys were fixed in 4% paraformaldehyde and embedded in paraffin. To
assay for immune complex deposition, paraffin-embedded 5m tissue sections
were dehydrated. The process of dehydration was done at room temperature by
immersing the sections in xylene I solution for 5 minutes, xylene II for 5 minutes,
absolute ethanol I for 3 minutes, absolute ethanol II for 3 minutes, 90% ethanol
for 3 minutes, 80% ethanol for 3 minutes and finally, 70% ethanol for 3 minutes.
Endogenous peroxidase activity was blocked using 1.5% H2O2 in PBS. After 3
wash cycles with PBS-T (5 minutes each), the slides were further blocked with
1%BSA in PBS for 45 minutes. The sections were then stained with biotin-goat
anti-mouse IgG (Fcγ-specific; 1/2000 dilution) for 2 hours, followed by
streptavidin-HRP (BD Pharmingen #550946) for 1 hour. Sections were washed
again with PBS-T (3 times, 5 minutes each). The peroxidase activity was
determined using DAB chromogen (BD #51-7549KC) for 5-10 minutes followed
by washing with distilled water. Hematoxylin staining was done for 1 minute and
sections were rehydrated. Rehydration was in the following order: 70% ethanol
for 1 minute, 80% ethanol for 1 minute, 90% ethanol for 1 minute, absolute
ethanol I for 1 minute, absolute ethanol II for 1 minute, xylene I for 2 minutes and
xylene II for 2 minutes. The sections were mounted with DPX and viewed under
200x and 400x light microscope.
3.2.14. RNA extraction using Trizol
RNA was extracted from whole spleen cells, purified CD4+ T cells, or
CD11b+ myeloid cells by the Trizol method. Cells (2-5 x 106 per sample) were
pelleted and resuspended in 1ml Trizol (Invitrogen #15596-018), following which
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200µl of chlorophorm was added and mixed well. Once the cells were spun down
at 14000 rpm for 10 minutes, 3 phases were obtained from which the top clear
RNA layer (~500µl) was transferred to a new tube. Equal volume of 2-propanol
(~500µl) was then added and mixed well to precipitate the RNA. Tubes were spun
again, supernatant was discarded and 500µl of 70% ethanol added. On flicking the
tubes, RNA was observed as a white pellet. Tubes were spun again, supernatant
was removed and RNA was finally suspended in 20µl nuclease free water and
stored at -80°C.
In studies involving whole spleen cells, the isolated RNA was further treated
with RNase-free DNase (Promega #M6101) to eliminate genomic DNA
contamination. In this process 2µg of RNA was treated with 2µl DNAase and 2 µl
DNAase buffer. Volume was made up to 20µl with nuclease-free water and
incubated at 37°C for 30 minutes in a theromomixer (Eppendorf). Stop solution
(2µl) was then added and incubated at 65°C for 10 minutes to inactivate the
DNase. The quality and quantity of the RNA was determined using the Nanodrop
ND-1000 spectrophotometer (Thermo Scientific, Waltham, MA).
3.2.15. Reverse Transcription Reaction
RNA was reverse transcribed using TaqMan reverse transcription reagent
(Applied Biosystems #N8080234). Each master mix reaction contained 10x RT
buffer, 25mM MgCl2, deoxy NTPs mixture (2.5mM), random hexamers (50µM),
RNAase inhibitor (20U/µl) and MultiScribe RT enzyme. The master mix was
aliquoted into separate PCR tubes. RNA was added (1µg/10µl per reaction) and
total volume was made up to 50µl with nuclease-free water. The one step RT-PCR
reaction was run on GeneAmp PCR System 2700 from Applied Biosystems, under
the following conditions: hexamer incubation for 10 minutes at 25°C, reverse
60

transcription at 48°C for 30 minutes and reverse transcriptase inactivation at 95°C
for 5 minutes. The samples were held at 4°C for a maximum of 1 hour until the
samples could be removed and stored at -20°C
3.2.16. Real time PCR reactions
The real time PCR was performed using TaqMan gene expression assay as
specified below and amplified using the 7500 Real Time PCR System (Applied
Biosystems). Each 20µl PCR reaction contained 10µl of 2xTaqMan Universal
Master Mix (Applied Biosystems #4440047), 1µl of 20x TaqMan assay Mix
(Applied Biosystems #4331182), 2µl cDNA and 7µl nuclease free water. A
negative PCR reaction was also carried out using only the reaction mixture
without cDNA in order to ensure that there was no DNA contamination .The
thermal cycling conditions were as follows: 95°C for 10 minutes (Inactivation of
Reverse Transcriptase and activation of TaqMan polymerase), 95°C for 15
seconds (denaturation of dsDNA) and 60°C for 1 minute (annealing/extensionfluorescent data collected during this step) for a total of 40 cycles with the
threshold set as 0.2. Data was analyzed using the Ct values for each sample that
were in duplicates. Results were normalized to HPRT (Hypoxanthine-guanine
phosphoribosyl transferase) and the mRNA fold change was determined using the
following equation:
Fold change= 2 [

Ct (infected)

]/2[

Ct (control)

], where

Ct(infected) = threshold cycle

(Ct) for target gene after infection - Ct for HPRT after infection and Ct(control)
= Ct for target gene saline treated - Ct for HPRT saline treated. Control used was
uninfected wild-type (C57BL/6).
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The assay ID of the primers used are as follows:
HPRT

(Mm01545399_m1),

IL-10

(Mm00484683_m1),

BAFF

(Mm00446347_m1), APRIL (Mm03809849_s1), GATA-3 (Mm00484683_m1),
IFN-γ

(Mm01168134_m1),

T-bet

(Mm00450960_m1),

RoRγ

(Mm01261022_m1), IL-17A (Mm00439618_m1), IL-17F (Mm00521423_m1),
IL-4

(Mm00445259_m1),

Foxp3

(Mm00475162_m1),

TGF-β

(Mm01178820_m1), IL-21 (Mm 00517640_m1), CXCR5 (Mm00432086_m1),
bcl-6 (Mm 00477633_m1)
3.2.17. Statistical analysis
Statistical significance was analyzed using Student's t-test or Mann-whitney
test, using the statistical program of GraphPad Prism software (San Diego, CA).
Differences between experimental groups were considered significant when p
values were <0.05.
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4.

RESULTS

4.1. Susceptibility of MyD88-/- mice to infection
The BRD509 strain of serovar Typhimurium is attenuated as a result of
deletions in the aroA and aroD genes. It is very efficient in affording protection
against virulent Salmonella challenge, with an immunizing dose of 105 CFUs per
mouse i.p., resulting in 100% protection against up to 10,000 LD50 dose of
virulent Salmonella. In Salmonella-susceptible mouse strains of diverse genetic
backgrounds, including C57BL/6 and BALB/c, the LD50 of the BRD509 strain is
>2 x 106 CFUs per mouse when given i.p. This contrasts with the virulent,
parental, bacterial strain, designated SL1344, which has a LD50 of <10 CFUs per
animal. In order to assess the effect of MyD88 deficiency on susceptibility to
Salmonella infection, MyD88-/- mice and their wild-type MyD88+/+ counterparts
were inoculated with different doses of BRD509 (range of 4 x 102 to 4 x 105
CFUs/mouse), following which animal survival was followed for up to 60 days.
As shown in Fig.1A, MyD88+/+ mice exhibited 100% survival even at the highest
inoculum dose used. In contrast, the survival rates of MyD88-/- mice were ~6%,
19%, 30% and 48% following inoculation with 4 x 105, 4 x 104, 4 x 103 and 4 x
102 organisms per animal, respectively. Moreover, the median survival for the
different groups was 20, 31, 36 and 59 days, respectively (Fig.1A). These findings
demonstrate that MyD88-/- mice are markedly more susceptible even to a highly
attenuated strain of Salmonella at a dose approximately 10,000-fold lower than the
LD50 dose in MyD88+/+ mice. The increased susceptibility of MyD88-/- mice to
Salmonella correlated with an inability to control bacterial proliferation in target
organs. In response to inoculation with a moderate dose of ~5 x 104 CFUs,
MyD88+/+ mice kept bacterial proliferation under control with less than 10-fold
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the inoculum being detectable in spleen or liver at any time after infection (Fig.
1B-C).
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Fig. 1. MyD88-deficient mice are hypersusceptible to Salmonella infection. (A) Wildtype C57BL/6 (MyD88+/+) and MyD88-deficient (MyD88-/-) mice were inoculated i.p.
with an attenuated strain of S. Typhimurium, designated BRD509, at the indicated doses.
Animal survival was followed for up to 60 days. The calculated median survival (in days)
for each group is shown. The results are pooled from 6 independent experiments. (B-C)
Mice were inoculated i.p. with 5 ×104 CFUs of BRD509 strain. At the indicated days post
inoculation, animals were sacrificed and the bacterial load in livers (B) and spleens (C)
were enumerated. Each data point represents the mean ± SEM of 5 mice per group.
Asterisks denote statistically significant differences between MyD88 -/- and MyD88+/+
mice (*p < 0.05; **p < 0.01; ***p < 0.001). The results are representative of 3
independent experiments. Data are based on Fig.1 of the paper Issac et al. 2013.
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In sharp contrast, proliferation of attenuated Salmonella organisms increased
over the 3 week-observation period, reaching approximately 1000-fold increase in
spleen and liver by day 21 post-infection. The extent of the susceptibility of
MyD88-/- mice was further examined by infecting the animals with a low dose of
BRD509 (~200 CFUs/mouse) and following bacterial shedding in the feces over a
4 week-period. As shown in Fig. 2A, a low level of detectable fecal shedding of
Salmonella organisms (~0.01 CFUs/mg feces) was seen only in week 2 postinfection in MyD88+/+ mice. By day 21 post-infection, as the infection had
cleared, no further shedding was observed. In contrast, MyD88-/- mice exhibited a
progressively worsening, persistent, infection accompanied by increasing levels of
bacterial shedding over the 4-week observation period (Fig. 2A). This also
corresponded to increased bacterial burden in the spleen and liver of infected
MyD88-/- mice where the bacteria recovered was about 100-200 fold greater than
in infected MyD88+/+ mice (Fig. 2B-C). Thus, there is a failure to control bacterial
replication in MyD88-/- mice even at a very low inoculum of an attenuated
Salmonella strain.
4.2. Defective recruitment of inflammatory cells and cytokine response
Given the critical role of MyD88 adaptor in TLR signaling and the innate
immune response, we reasoned that the failure to control bacterial proliferation
may be due to an early defect in the response to Salmonella infection. A critical
step in the innate immune response to an intraperitoneal route infection with
Salmonella is the recruitment of inflammatory cells into the peritoneal cavity
within the first 48 hours of infection. Analysis of peritoneal cell exudates (PECs)
in infected mice revealed a delayed cellular influx in MyD88-/- mice (Fig. 3A). At
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Fig. 2. Increased fecal shedding of Salmonella in infected MyD88-/- mice. Mice were
inoculated i.p. with a low dose of BRD509 (~200 CFUs/mouse) and the extent of
bacterial shedding in the feces (A) and bacterial load in spleen (B) and liver (C) were
enumerated. Each data point represents the mean ± SEM of 6-10 mice per group.
Asterisks denote statistically significant differences between MyD88-/- and MyD88+/+
mice (*, p<0.05; **, p<0.01). The results are representative of 3 independent experiments.
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2 hours post-infection, the number of PECs in MyD88+/+ mice was 19% higher
than that observed in MyD88-/- mice. By 24 hours, the mean PECs count in
MyD88+/+ mice was 5-fold higher than in MyD88-/- mice (8 x 106 vs 1.6 x 106
cells, respectively). Based on the kinetics of cell recruitment, the response peaked
at 24 hours in wild-type mice, whereas it was minimal at 24 hours and was still
rising at 48 hours in MyD88-/- mice.
In addition to this quantitative delay in cell recruitment, flowcytometric
analysis of PECs collected 48 hours post-infection demonstrated a significant
defect in recruitment of inflammatory cells, exemplified by CD11b+Gr-1+
neutrophils, in MyD88-/- mice. In terms of absolute counts, these cells constituted
up to 3 x 106 (~55%) of total PECs in infected wild-type mice but only 0.5 x 106
(~8%) of PECs in MyD88-/- mice (Fig. 3B). These results reveal quantitative as
well as qualitative alterations in inflammatory cell recruitment between infected
wild-type and MyD88-/- mice.
Resistance to Salmonella infections is dependent on a robust Th1 response
which leads to the activation of host macrophages and elimination of intracellular
pathogens (Mastroeni et al., 1998). We therefore analyzed cytokine production in
wild-type and MyD88-/- mice during the innate immune phase of the infection.
Production of IL-6, IL-12, and nitric oxide (NO) was undetectable in ex vivocultured PECs from MyD88-/- mice within the first 48 hours of Salmonella
infection (Fig. 3C-E, respectively). This is in contrast to infected MyD88+/+ mice,
in which production of IL-6, IL-12 and NO was readily detectable at 48 hours
post-infection. These results are in agreement with previous studies that
documented a defect in production of IL-1β, TNF-α and IL-6 in MyD88-/- mice
(Kawai et al., 1999); (Weiss et al., 2004).
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Fig. 3. Defective recruitment and activation of inflammatory cells in infected
MyD88-/- mice. Following inoculation of BRD509 (∼3 × 105/mouse), the number of total
peritoneal exudate cells (PECs) were enumerated at 2, 24 and 48 hrs time points (A).
After staining with mAbs to CD11b and Gr-1 and analysis by flow cytometry, the number
of CD11b+Gr-1+ neutrophil population was determined at 48 hrs post-infection (B). Total
PECs were collected from either saline-treated or Salmonella-infected mice at 24 and 48
hrs and cultured overnight without additional stimulation. Cell-free culture supernatants
were tested for IL-6 (C), IL-12p40 (D) and nitric oxide (E). Each data point represents the
mean ± SEM of 3–5 mice per group, compiled from 2 independent experiments. Date are
based on Fig. 2A and 2D and Fig. 4 A-C from the paper Issac et al,2013.
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4.3. MyD88-/- mice exhibit dysregulated antibody responses following
Salmonella infection
Systemic infection with Salmonella organisms typically leads to the
induction of Th1-driven antibody production, characteristically of the IgG3 and
IgG2c isotypes in C57BL/6 mice (al-Ramadi et al., 2006); (Harrison et al., 1997).
Given the increased susceptibilty of MyD88-/- mice to Salmonella infection, we
reasoned that anti-Salmonella antibody responses would likely be also
compromised in these animals. To test this hypothesis, mice were infected i.p.
with a low dose of BRD509 (~200 CFUs/mouse) and sera collected 4-6 weeks
later for the determination of isotype-specific, anti-Salmonella antibody levels. In
C57BL/6 mice, BRD509 infection induced a predominantly Th1-driven antibody
response, exemplified by IgG3 and IgG2c isotypes (Fig. 4B-C). Infection of
MyD88-/- mice induced the production of significantly higher levels of antiSalmonella antibodies of IgG3, IgG2c as well as IgM isotypes (Fig. 4A-C). Even
more surprisingly, Salmonella-specific antibodies of the Th2-driven IgG1 isotype
were detected in MyD88-/- mice, an isotype not commonly associated with
Salmonella infections in wild-type, MyD88+/+ mice (Fig. 4D). The absolute levels
of Salmonella-specific IgG1 and IgG2c were also determined using known
standards (shown in Fig. 5A-B) and the calculated concentrations in the various
treatment groups were in agreement with the results shown in Fig. 4. Thus, despite
their increased susceptibility to Salmonella, MyD88-/- mice exhibit a state of
infection-induced hypergammaglobulinemia which was evident in all of the tested
antibody isotypes.
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Fig. 4. Hypergammaglobulinemia in Salmonella-infected MyD88-/- mice. Mice were
inoculated i.p. with BRD509 (∼200 CFUs/mouse) and sera collected at 4-6 weeks and
analyzed for the presence of Salmonella-specific IgM (A), IgG3 (B), IgG2c (C) and IgG1
(D) isotypes. Asterisks denote statistically significant differences between the indicated
experimental groups (*, p<0.05; **, p<0.01; ***, p<0.001). Data are pooled from 3
independent experiments.
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Fig. 5. Quantification of Salmonella-specific serum. IgG2c (A) and IgG1 (B) antibodies
in non-infected (NI) and 3 week-infected (I) mice. Attenuated BRD509 strain was used
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ng/ml serum. Asterisks denote statistically significant differences between infected
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The kinetics of the early development of isotype specific antibodies to
Salmonella organisms were evaluated at weekly intervals following inoculation.
Wild-type mice developed anti-Salmonella antibodies of IgG2c and IgG3 isotypes
of increasing concentrations over the 3 week-observation period (Fig. 6A-B). No
significant Salmonella-specific antibodies of IgG1 isotype were observed in
C57BL/6 mice (Fig. 6C). In contrast, starting at 14 days post-infection, MyD88-/mice secreted Salmonella-specific antibodies of all three (IgG2c, IgG3 and IgG1)
isotypes at higher levels than seen in C57BL/6 mice (Fig. 6A-C). Thus, the state
of hypergammaglobulinemia in infected MyD88-/- mice became evident as early
as 14-21 days post Salmonella inoculation and was still significant up to 2 months
later (the longest period of observation).

72

(A)

IgG3

1.0

O.D. (450nm)

MyD88+/+
0.8

MyD88-/-

*

0.6
0.4
0.2
0.0

O.D. (450nm)

(B)

7
0.4

14

21

IgG2c

0.3
0.2
0.1
0.0

(C)

7

O.D. (450nm)

0.6

14

21

IgG1
*

0.4

0.2

0.0
7

14

21

Days Post Infection

Fig. 6. Kinetics of development of anti-Salmonella antibodies. The development of
antibodies to Salmonella infection was evaluated up to 3 weeks post i.p infection with a
dose of 4000 CFUs/mouse. Salmonella specific IgG3 (A), IgG2c (B), and IgG1 (C) were
determined. Data are compiled from 3 independent experiments. Asterisks denote
statistically significant differences between MyD88-/- and MyD88+/+ mice (*, p<0.05).
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The effect of MyD88 deficiency on global antibody levels was evaluated by
quantitating the concentrations of total serum IgG3, IgG2c, and IgG1 isotypes in
both MyD88+/+ and MyD88-/- mice before and after infection with Salmonella. In
uninfected animals, relatively low levels of serum IgG3 and IgG2c were detected
but they were equivalent in both MyD88+/+ and MyD88-/- mouse strains (Fig. 7AB). Serum IgG3 concentrations were 45 ± 9 µg/ml (mean ± SEM) and 44 ± 27
µg/ml for MyD88+/+ and MyD88-/- mice, respectively (Fig. 7A). For IgG2c, serum
concentrations were 554 ± 94 µg/ml and 307 ± 37 µg/ml for MyD88+/+ and
MyD88-/- mice, respectively (Fig. 7B). In infected mice, serum IgG3 and IgG2c
concentrations were increased significantly by an average of 3-5 fold over those in
uninfected mice. In contrast, baseline serum IgG1 concentrations in uninfected
MyD88-/- mice were significantly elevated compared to MyD88+/+ mice (2.3+ 0.7
vs 0.63 + 0.1 mg/ml, respectively; Fig. 7C). However, no significant changes in
serum IgG1 concentrations were observed upon infection with Salmonella in both
mouse strains. These findings indicate that the humoral immune response in
MyD88-/- mice is constitutively skewed to Th2-induced IgG isotypes.
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Fig. 7. Salmonella-induced dysregulation in total serum antibodies in MyD88-/- mice.
Following infection with BRD509 (~200 CFUs/mouse), sera were collected 4-6 weeks
later. Total serum IgG3 (A), IgG2c (B), and IgG1 (C) in both infected and non-infected
mice were quantified by ELISA. Each data point represent mean ± SEM of 3–10 mice per
group (*, p<0.05).

75

4.4. Oral Salmonella inoculation leads to persistent infection in MyD88-/- mice
Since MyD88-/- mice were hypersusceptible to systemic Salmonella
infections, their response to an oral administration of BRD509 strain was
investigated. Unlike systemic infections, mice inoculated orally with doses of up
to 1 x 109 CFUs/animal exhibited 100% survival and had no signs of morbidity for
up to 60 days post-infection (data not shown). Long-term persistence of oral
infections was followed by quantitating the extent of bacterial shedding in the
feces for 6 months. In MyD88+/+ mice, fecal shedding of bacteria was evident up
to 2 weeks post-infection with ~1 x 108 CFUs/mouse (Fig. 8A). At later time
points, no significant shedding was observed. In contrast, substantial shedding of
Salmonella organisms was evident in infected MyD88-/- mice for the entire
observation period (up to day 191 post-infection).
Bacterial loads were also determined in mesenteric lymph nodes (MLNs),
livers and spleens of infected mice at different time points post oral infection (Fig.
8B-D). Consistent with the findings from systemic infection, MyD88-/- mice
harbor significantly increased loads (~10 to 100-fold) of BRD509 organisms in
their tissues compared with wild-type mice over the first 3 weeks of infection. As
expected, the highest concentration of bacteria was found in MLNs but even here
differences between wild-type and MyD88-deficient mice were found throughout
the observation period (Fig. 8B), suggesting that MyD88 is also important for
immune defense along mucosal tissues. Assessment of spleen weights in orally
infected mice also reflected a pattern previously observed with systemic infections
(Fig. 8E). Thus, early on, spleen weights of infected MyD88-/- mice lagged behind
those of wild-type counterparts, perhaps reflecting the defective recruitment of
inflammatory cells. By day 21 post-infection, as bacterial proliferation was
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brought under control, splenomegaly in wild-type mice began to normalize.
However, the degree of splenomegaly continued to increase in infected MyD88-/mice most likely as a reflection of their failure to control the infection (Fig. 8E).
Interestingly, while infected MyD88-/- mice exhibited continuous shedding of
bacteria in the feces (Fig. 8A), no Salmonella organisms were detectable in
spleens and livers of these animals at day 191 after infection (data not shown).
Therefore, in the absence of MyD88 protein, oral administration of an attenuated
Salmonella strain leads to a long-term persistent infection that appears to be
restricted to the mucosal tract.
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Fig. 8. Oral infection with attenuated Salmonella leads to persistent infection. Mice
were inoculated orally with BRD509 (~1 x 108 CFUs/mouse). Shedding of Salmonella
organisms in the feces was followed for up to 27 weeks (A). (B-D) Mice were inoculated
orally with ~1 x 109 CFUs/mouse of BRD509 strain and bacterial load in mesenteric
lymph nodes (MLNs; B), liver (C) and spleen (D) was enumerated at the indicated time
points. Degree of splenomegaly was also determined (E). Asterisks denote statistically
significant differences between MyD88-/- and MyD88+/+ mice (*, p<0.05; **, p<0.01; ***,
p<0.001). The experiment was performed twice with similar results.
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Next, the systemic and mucosal Salmonella-specific antibody levels were
evaluated after oral infection in normal and MyD88-/- mice. Consistent with the
findings of systemic infections, orally-infected MyD88-/- mice had elevated levels
of Salmonella-specific IgG3, IgG2c and IgG1 antibodies (Fig. 9A-C). In normal
mice, the most significant rise in anti-Salmonella antibodies was in the IgG2c
isotype (Fig. 9B). No significant differences in serum IgA levels were observed
between the mouse strains following infection (Fig. 9D). However, a significantly
stronger mucosal IgA response was observed in infected wild-type mice compared
to MyD88-/- counterparts, despite the higher levels of bacterial persistence seen in
the latter mouse strain (Fig. 9E). These data demonstrate that the induced
hypergammaglobulinemia in MyD88-/- mice is not restricted to systemic
infections. In contrast, MyD88 protein appears to be essential for the induction of
a robust mucosal IgA response. Taken together, these findings suggest that the
systemic antibody response is fundamentally dysregulated in MyD88-/- mice.
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Fig. 9. Elevated serum but not mucosal antibody levels following oral infection with
BRD509 in MyD88-/- mice. Animal sera were tested at 3-6 months after infection for the
presence of Salmonella-specific IgG3 (A), IgG2c (B), IgG1 (C) and IgA (D) antibody
isotypes. Mucosal IgA levels were also determined in fecal pellets at the same time (E).
Data are compiled from 2 independent experiments. Asterisks denote statistically
significant differences between MyD88-/- and MyD88+/+ mice (***, p<0.001).
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4.5. Breakdown of humoral self-tolerance in MyD88-/- mice following systemic
Salmonella infection
Given the observed dysregulation in antibody synthesis in Salmonellainfected MyD88-/- mice, the potential generation of autoantibodies was examined
in these mice. Polyclonal B cell activation in response to infections has been
shown to cause hyper antibody responses that could lead to autoimmunity (Woods
et al., 2008); (Ko et al., 2011). Sera were collected 4-6 weeks following i.p
infection and tested for reactivity against a panel of self antigens including
dsDNA, thyroglobulin and IgG. To rule out non-specific cross-reactivity, all
autoantibody ELISAs were determined at a serum dilution of 1/1000 or greater.
The data illustrate the presence of significant titers of autoantibodies to dsDNA,
thyroglobulin and IgG (RF) in Salmonella-infected MyD88-/- mice (Fig. 10A-C).
Importantly, sera from uninfected MyD88-/- mice had no reactivity to any of the
autoantigens. Similarly, no autoreactive antibodies were detectable in wild-type
(MyD88+/+) mice before or after infection. These findings provide evidence for the
secretion of autoantibodies in MyD88-/- mice, but not for normal mice, following
infection with Salmonella.
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Fig. 10. Autoantibody reactivity of MyD88-/- sera after systemic Salmonella infection.
Sera were collected 4-6 weeks following i.p. infection with BRD509 (~200 CFUs/mouse)
and tested for reactivity with dsDNA (A), thyroglobulin (B) and rheumatoid factor (RF;
C) by specific ELISA. The cut-off for the detection of these autoantibodies was
determined at 1/1000 dilution. Date compiled from 3 independent experiments. (*,
p<0.05; **, p<0.01).
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Autoantibodies targeting dsDNA, histones and other nuclear antigens can
also be determined by immunofluorescence using HEp-2 human epithelial cells.
The presence of anti-nuclear antibodies (ANA) has been strongly associated with
various autoimmune mouse models (Silver et al., 2007); (Sadanaga et al., 2007);
(Bolland et al., 2002). To determine the overall levels of ANA, we assayed the
reactivity of serially diluted sera to fixed HEp-2 cells by immunofluorescence.
Approximately 53% of sera (8 out of 15) collected from Salmonella-infected
MyD88-/- mice showed strong reactivity with HEp-2 cells (Fig. 11G). Importantly,
these sera exhibited different staining patterns, such as homogenous and
fine/coarse speckled (Fig. 11D-F), reflecting the different nuclear antigens being
recognized. In contrast, only about 8% of the sera from infected MyD88+/+ mice (1
out of 12) were positive for HEp-2 staining (Fig. 11C, G). Non-infected mice of
both strains were all negative (Fig. 11A-B). Positive ANA staining with HEp-2
cells generally correlated with high anti-dsDNA antibody levels.
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Fig. 11. Immunofluoresence detection of HEp-2 cell ANA reactivity of sera from
Salmonella-infected MyD88-/-. ANA staining obtained with sera from non-infected (AB) and infected (C-F) MyD88+/+ (A, C) and MyD88-/- (B, D-F) mice. Different staining
patterns are detected, including homogenous (D), speckled (E), and cytoplasmic (F).
Negative staining is depicted in panels A-C. The percentage of different experimental
groups (5-15 mice/gp) that were positive for ANA is summarized in panel G. The
fluorescence was visualised at 400x magnification using an Olympus fluorescent
microscope. Data are compiled from 2 independent experiments.
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Given the state of hypergammaglobulinemia and the increased levels of
serum IgG autoantibodies in infected MyD88-/- mice, we next evaluated whether
this was associated with more abundant deposits of immune complexes in kidney
glomeruli. No evidence of staining was detected in the glomeruli of non-infected
MyD88-/- or MyD88+/+ mice (Fig. 12A, D). In comparison, about 20% of infected
MyD88+/+ mice showed positive staining of glomeruli but those were generally of
low level of intensity (Fig. 12E-F). In sharp contrast, much brighter staining,
indicating more deposits of immune complexes, was detected in ~69% of
Salmonella-infected MyD88-/- mice (Fig. 12B-C, G). Thus, the absence of MyD88
predisposes animals to hypergammaglobulinemia, production of autoantibodies,
and deposition of immune complexes in kidney glomeruli following infection with
Salmonella.
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Fig. 12. Immunoglobulin deposition in kidney sections of Salmonella infected
MyD88-/- mice. Kidney sections were prepared from non-infected (A, D) and infected (B,
C, E, F) MyD88-/- (A-C) and MyD88+/+ (D-F) mice and stained with anti-IgG antibody,
as described in M&M. (G) The percentage of mice whose kidney sections scored positive
for the presence of immune deposits by DAB staining. Images were taken at 400x
magnification. Data are compiled from 2 independent experiments.
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4.6. Requirements for infection-induced hypergammaglobulinemia and
autoantibody production
The next series of experiments were designed to study the requirements for
the observed hypergammaglobulinemia and autoantibody synthesis in MyD88-/mice. We first evaluated whether infection with another Gram-negative bacterium,
Acinetobacter baumanii, could lead to similarly dysregulated antibody production.
Mice infected with a dose of ~1 x 105 organisms of Acinetobacter baumanii
(strain NM970) still harbored bacteria in spleen and liver 2 months following
inoculation, with higher bacterial loads than those being observed in MyD88-/mice (Fig. 13A-B). Infected wild-type mice were strongly positive for
Acinetobacter-specific antibodies, predominantly of IgG3 isotype (Fig. 13C).
Interestingly, infected MyD88-/- mice also developed mainly IgG3 antibodies
specific to Acinetobacter, but they were significantly lower than those observed in
infected MyD88+/+ mice (Fig. 13C). No significant bacteria-specific IgG2c or
IgG1 antibodies were detected (Fig. 13D-E). Thus, infection with a nonintracellular Gram-negative pathogen failed to induce hypergammaglobulinemia
in MyD88-/- mice, as observed with Salmonella bacteria.
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Fig. 13. No evidence for immunoglobulin dysregulation in MyD88-/- mice following
infection with Acinetobacter baumanii. Two months post i.p. infection with a dose of ~1
x 105 CFUs/mouse of A. baumanii, bacterial counts in spleen (A) and liver (B) were
enumerated. Serum levels of anti-acinetobacter IgG3 (C), IgG2c (D) and IgG1 (E)
isotypes were determined at 6-8 weeks post -infection.(*, p<0.05, ****, p<0.0001). Data
are compiled from 2 independent experiments.
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The presence of antibodies specific to dsDNA and thyroglobulin was also
tested in these mice following Acinetobacter infection. However, no
autoantibodies were detectable in any of the experimental groups (Fig. 14A-B).
Furthermore, there was no evidence of antibody dysregulation or autoantibody
production in MyD88-/- mice infected with the Gram-positive bacteria, Group B
Streptococcus (Streptococcus agalactiae), or another Gram-negative pathogen E.
coli (data not shown).
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Fig. 14. Serum reactivity to dsDNA and thyroglobulin following A. baumanii
infection. Serum reactivity to dsDNA (A) and thyroglobulin (B) were determined 6-8
weeks post-infection with A. baumanii. The cut off for the detection of these
autoantibodies was determined at 1/1000 dilution. Data are compiled from 2 independent
experiments.
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The capacity of heat-killed (HK) Salmonella (strain BRD509) to induce a
state of hypergammaglobulinemia was also tested. Following injection with
2 x 105 HK Salmonella organisms, low levels of IgG3 antibodies were detected in
MyD88+/+ mice which were similar to the levels produced after live infection (Fig.
15A). In contrast to infection with live bacteria, however, no IgG2c antibodies
were detected in response to HK bacteria in MyD88+/+ mice (Fig. 15B). Another
difference in isotype profile, was the induction of IgG1 antibodies seen in
MyD88+/+ mice after injection of HK, but not live, Salmonella (Fig. 15C). In
sharp contrast to live Salmonella infection, MyD88-/- mice injected with HK
BRD509 strain produced largely IgG1 but not any significant IgG3 or IgG2c
isotype antibodies (Fig. 15A-C). Thus, injection with HK bacteria favors the
induction of predominantly Salmonella-specific IgG1 antibodies in both mouse
strains with no evidence of hypergammaglobulinemia being observed in MyD88-/mice.
In line with these observations, sera collected from HK Salmonella-injected
mice also failed to show any reactivity to dsDNA. This was true for both wildtype and MyD88-/- mice (Fig. 15D). Taken together, these results indicate that
heat-killed Salmonella fail to induce dysregulated antibodies, suggesting the
nature of the bacterial antigen is critical for the observed breakdown in selftolerance that is observed in MyD88-/- mice.
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Fig. 15. Absence of immunoglobulin dysregulation and autoantibodies in MyD88-/mice following injection of heat-killed BRD509. Serum levels of Salmonella-specific
IgG3 (A), IgG2c (B) and IgG1 (C) antibodies were determined at 8 weeks post i.p
inoculation of 2 x 105 heat-killed (HK) BRD509 in comparison to those observed in
response to live BRD509 infection. (D) Serum reactivity to dsDNA in heat-killed vs live
Salmonella infected mice. The cut-off for the detection of dsDNA was determined at
1/1000 dilution. Data are compiled from 2 independent experiments (*, p<0.05; **,
p<0.01; ***, p<0.001).
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4.7.

Regulation

of

hypergammaglobulinemia

by

cytokine-expressing

Salmonella strains
It is clear from the data thus far, that infection of MyD88-/- mice with an
attenuated strain of Salmonella leads to dysregulated humoral immune responses
in which pathogen-specific antibodies of all IgG isotypes are produced at high
levels. Immunoglobulin class switching is largely regulated by T cell-derived
cytokines such as IFN-γ and IL-4, which are produced by Th1 and Th2 cells,
respectively. Our laboratory has previously demonstrated the potential of
manipulating the anti-Salmonella immune response in wild-type mice by using
recombinant Salmonella strains engineered to express specific murine cytokines
(al-Ramadi et al., 2001); (Al-Ojali et al., 2012b). Two of these strains, GIDIL2
and GIDIFN, which express IL-2 and IFN-γ respectively, were therefore used to
study their effect on humoral immune responses in MyD88-/- mice. These
cytokines are important regulators of the Th1 response required for protection
against intracellular bacterial infection in C57BL/6 mice. The bacterial load in the
spleen and liver were determined at 4 weeks post-infection with a low dose of
BRD509 (~200 CFUs/mouse) (as shown earlier) or GIDIFN. As described earlier,
the bacterial loads in the spleen and liver of MyD88-/- mice after BRD509
infection were 100-200 fold greater than in the infected wild-type mice (Fig. 16AB). Similarly, using the GIDIFN strain, the bacterial load recovered in the target
organs of the MyD88−/− mice were 400-500 fold greater than in the wild-type
mice (Fig. 16A-B). Notably, the bacterial loads in GIDIFN-infected MyD88-/mice were 1.5-2.6 fold lower than those infected with BRD509. In MyD88+/+
mice, the differences in bacterial loads between BRD509- and GIDIFN-infected
mice approached 4-9 fold (Fig. 16A-B). This suggests that IFNγ-expressing
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Salmonella strain is cleared more robustly by both mouse strains compared to
BRD509. The observations in wild-type mice are consistent with previous data
from our laboratory (Al-Ojali et al., 2012a).
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Fig. 16. Hypersusceptibility of MyD88-/- mice to infection with an IFN-γ-expressing
Salmonella strain, GIDIFN. Mice were inoculated i.p. with GIDIFN or its parental strain
BRD509 (~200 CFUs/mouse) Bacterial loads in the spleen (A) and liver (B) were
enumerated at 4 weeks post-infection (*, p<0.05; **, p<0.01).
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Salmonella-specific antibody responses were compared in normal or
MyD88-/- mice 4-6 weeks following a low dose (~200 CFUs/mouse) infection
with GIDIFN, GIDIL2 or BRD509 strain. In C57BL/6 mice, significant titers of
IgG3 and IgG2c isotypes were observed after infection, with the former being
predominant in BRD509-infected mice and the latter in mice infected with either
GIDIL2 or GIDIFN strain (Fig. 17A-B). Importantly, no IgG1 antibodies were
detectable in wild-type mice following infection with any of the Salmonella
strains (Fig. 17C). In contrast, compared to wild-type animals, MyD88-/- mice
consistently produced significantly higher levels of antibodies of all three isotypes
to all Salmonella strains, with the sole exception of IgG2c isotype in GIDIL2infected mice (Fig. 17A-C). It is also interesting to note that infection with
GIDIFN, but not GIDIL2, strain appeared to enhance Th1-driven isotypes (IgG2c
and IgG3) and reduce Th2-driven IgG1 isotype in MyD88-/- mice. Overall, a state
of hypergammaglobulinemia was still evident in MyD88-/- animals following
infection with recombinant, cytokine-expressing, Salmonella strain.
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Fig. 17. Induction of hypergammaglobulinemia in MyD88-/- following infection with
two different cytokine-expressing Salmonella strains. Mice were inoculated i.p. (~200
CFUs/mouse) with BRD509 or its recombinant derivatives, the IFNγ-expressing
(GIDIFN) or IL-2-expressing (GIDIL2) strain. Salmonella-specific antibodies of the IgG3
(A), IgG2c (B) or IgG1 (C) isotypes were determined at 4-6 weeks post-infection. Data
are compiled from 2 independent experiments for cytokine expressing strains and 3
independent experiments for the BRD509 strain (*, p<0.05; **, p<0.01; ***, p<0.001).
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The presence of autoreactive antibodies specific to dsDNA and thyroglobulin
was determined in sera of infected mice at 4-6 weeks post inoculation. As shown
in Fig. 18A-B, significant reactivity to the two self antigens was observed in
MyD88-/- mice infected with the BRD509 strain. Sera of MyD88-/- animals
infected with either GIDIFN or GIDIL2 failed to exhibit any significant reactivity
to self antigens. Sera of infected wild-type mice, regardless of the Salmonella
strain used, were also negative.
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Fig. 18. No evidence for autoantibody induction in mice infected with cytokineexpressing Salmonella strains. Serum reactivity to dsDNA (A) and thyroglobulin (B)
following infection with BRD509, GIDIFN or GIDIL2 Salmonella strains in WT and
MyD88-/- mice. The cut off for the detection of autoantibodies was determined at 1/1000
dilution. Data are compiled from 2 independent experiments for cytokine expressing
strains and 3 independent experiments for the BRD509 strain (**, p<0.01).

96

4.8. Flowcytometric analysis of the cellular alterations following infection of
MyD88+/+ and MyD88-/- mice
In an effort to better understand the underlying mechanism for the observed
hypergammaglobulinemia in MyD88-/- mice, the cellular changes in the spleen
following infection were characterized by flowcytometry. This analysis was
carried out at 3 weeks post-infection since this is the time at which elevated serum
antibodies began to be observed. Normal or MyD88-/- mice were infected with
~3000 CFUs/mouse of BRD509 strain and sacrificed at day 21 for analysis. As
expected, inoculation of MyD88-/- mice with this rather low dose of attenuated
Salmonella results in bacterial persistence in target organs as evidenced by the
significantly larger loads in liver and MLNs (Fig. 19C-D). This is accompanied by
a protracted state of splenomegaly in MyD88-/- mice characterized by significantly
larger (~3.8-fold) spleens compared to infected MyD88+/+ mice (Fig. 19A-B).
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Fig. 19. Splenomegaly elevated bacterial organ loads in infected MyD88-/- mice. Mice
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enlarged spleens are observed, particularly in infected MyD88-/- mice (panels A-B).
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independent experiments (*, p<0.05, ***, p<0.001).
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Flowcytometric analysis was carried out on spleen cell populations from noninfected as well as infected animals using a panel of monoclonal antibodies
(mAbs) specific to each major cell population as well as a series of activation
markers for each cell subpopulation. Based on staining with a combination of
mAbs to CD11b and Gr-1 cell surface molecules, three CD11b+ myeloid
subpopulations could be discerned, Gr-1H, Gr-1Int and Gr-1L which represent
granulocytes, activated macrophages and monocytes, respectively (Fig. 20). In the
spleens of non-infected C57BL/6 mice, the mean percentages of each of these
populations were 2.0 ± 0.5, 3.2 ± 0.7, and 6.2 ± 1.3, respectively (Fig. 20A and
Fig. 21A). By day 21 post-infection with BRD509 strain, a time by which the
infection has been largely resolved in wild-type mice, the respective percentages
were 4.4 ± 0.4, 6 ± 0.7, and 5.2 ± 0.5 (Fig. 20C and Fig. 21A), representing about
2-fold increase in percentage of Gr-1H and Gr-1Int myeloid cell populations. The
cellular changes observed in the spleens of MyD88-/- mice were more profound
(Fig. 20B, D and Fig. 21A); the percentages of Gr-1H, Gr-1Int and Gr-1L cells
increased from 0.7 ± 0.2, 1.8 ± 0.1, and 4.7 ± 0.4 in non-infected mice to 3.7 ± 0.5,
14.2 ± 2.2, and 4.5 ± 0.3 in infected animals, respectively. These results represent
~5-fold and ~8-fold increase in Gr-1H and Gr-1Int myeloid cells, largely as a
consequence of the persistent infection in MyD88-/- mice. No significant
differences were observed in the CD11b+Gr-1low myeloid subpopulation in either
mouse strain (Fig. 21A).
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Fig. 20. Flow cytometric analysis of inflammatory myeloid cell influx and activation
status in the spleen. Splenocytes were prepared from non-infected (A-B) or Salmonellainfected (C-D) MyD88+/+ (A, C) or MyD88-/- (B, D) mice and analyzed for CD11b and
Gr-1 positivity. Analysis was done on day 21 post-infection with the BRD509 strain.
Based on level of expression of Gr-1 protein, three distinct CD11b+ myeloid populations
could be discerned in each experimental mouse group, CD11b+Gr-1high (top panel),
CD11b+Gr-1Inter (middle panel), and CD11b+Gr-1−/low (bottom panel). Each of these subpopulations was further analyzed for the expression of CD80 and Sca-1 activation
markers, as indicated. Cell percentages are shown in each quadrant. Results of individual
mice are shown and are representative of four independent experiments.
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The activation status of the various populations of myeloid cells was also
assessed by co-staining with antibodies to Sca-1 and CD80 proteins. Salmonella
infection induced a dramatic upregulation of Sca-1 expression on all myeloid cell
populations in both mouse strains. Within the infected groups, the level of Sca-1
expression was higher in MyD88-/- than in MyD88+/+ mice (Fig. 21B). This
suggests a robust IFNγ-driven up regulation following infection. Interestingly in
the Gr-1L monocytic populations, the MyD88-/- controls exhibited a higher level of
Sca-1 expression than the wild-type control group (Fig. 21B). Regarding CD80
expression, the majority of myeloid cells in non-infected mice showed substantial
levels of CD80 (Fig. 21C) and there was no significant alteration in the expression
of this costimulatory molecule in any of the myeloid populations after infection in
either of the two mouse strains (Fig. 20C-D and 21C). Thus, by day 21 post
inoculation, persistence of Salmonella infection in MyD88-/- mice correlated with
increased expansion of activated splenic macrophages and granulocytes which
was more apparent than in MyD88+/+ counterparts in which the infection had
largely been resolved by that time.
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Fig. 21. Quantification of alterations in splenic myeloid cell sub-populations and
their activation status following infection. (A). Percentages of CD11b+ myeloid cells
expressing either high, intermediate or low levels of Gr-1 protein in non-infected or
BRD509-infected MyD88+/+ or MyD88-/- mice. (B-C) Alterations in expression of Sca-1
(B) or CD80 (C) proteins in the different myeloid subpopulations. Graphs are compiled
from 4 independent experiments (*, p<0.05, **, p<0.01).
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4.9. Enhanced lymphocyte activation in the spleens of Salmonella-infected
MyD88-/- mice

We further assessed the splenic population of B lymphocytes (Fig. 22A) and
their activation status after infection at day 21. In saline-treated MyD88-/- mice,
CD19+ B lymphocytes constituted ~55% of the splenic population which was
slightly higher than those observed in the wild-type strain (~49.3%). After
Salmonella infection, percentage of B lymphocytes decreased to 37% in MyD88-/mice compared to 44% in MyD88+/+ mice (Fig. 22B).
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Fig. 22. Flow cytometric analysis of splenic CD19+ B lymphocytes in various
experimental animal groups. (A) representative dot blot of gated CD19+ cells. (B)
Percentage of CD19+ B cells in infected and non-infected groups. Analysis was done on
day 21 post-infection with the BRD509 strain. Data are compiled from 4 independent
experiments (**, p<0.01).
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The activation status of B cells was determined by evaluating the expression
of Sca-1, CD80 and CD86 markers. Representative dot plots of Sca-1 and CD80
staining are shown in Fig. 23 and quantitative analysis for each marker is shown
in Fig. 24A-C. The majority of B cells from both mouse strains (51% and 75% in
MyD88+/+ and MyD88-/-, respectively) were positive for Sca-1 in normal animals.
After infection, the percent positive cells increased to 92% and 99%, respectively
(Fig. 23C-D and Fig. 24A). In contrast, CD80 expression was not induced upon
infection on B cells of either mouse strain (Fig. 24B). However, the percentage of
B cells expressing CD86 increased by 2-fold and 3-fold in infected MyD88+/+ and
MyD88-/- mice, respectively (Fig. 24C). Thus, B lymphocytes of MyD88-/- mice
appear to be at a heightened level of activation, especially after Salmonella
infection.
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Fig. 23. Increased B lymphocyte activation in the spleens of MyD88-/- mice following
infection with Salmonella. Dot plots depicting the level of expression of Sca-1 and
CD80 proteins on gated CD19+ B cells in non-infected (A-B) and Salmonella infected (CD) MyD88+/+ (A, C) or MyD88-/- (B, D) mice. Numbers within quadrants represent
percentage of positive cells in that population. Analysis was done on day 21 postinfection with the BRD509 strain. Results of individual mice are shown and are
representative of four independent experiments.
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The splenic CD3+ T cell populations, their subsets and activation status were
also evaluated at day 21 post-infection. A representative dot plot of the gated
CD3+ T cells (Fig. 25A) and their CD4+ and CD8+ subsets (Fig. 25C) is shown.
The CD3+ T cells constituted up to 33% of the splenic populations in wild-type
mice which did not change significantly on infection (Fig. 25B). However,
infected MyD88-/- mice were observed to have significantly lower percentages
(~26%) of CD3+ T cells (Fig. 25B). On evaluating the T cell subsets, the decrease
of CD3+ T cells in the infected MyD88-/- mice constituted mainly a reduction in
the percentage of CD8+ T cells and not CD4+ T cells (Fig. 25D).
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Using appropriate gates, the expression of activation markers CD25 and Sca1 was studied on CD4+ and CD8+ T cells (Fig. 26 and 27). Similar to previous
observations with B cells, the great majority of CD4+ T cells in uninfected spleens
(76% and 85% in MyD88+/+ and MyD88-/- mice, respectively) were positive for
Sca-1 antigen (Fig. 26A-B). These percentages were further increased to >94% in
infected mice. A much more limited expression of CD25 was observed on CD4+ T
cells (Fig. 26A, C). In non-infected mice, only 7-8% of CD4+ T cells were
positive for CD25 (Fig. 26C). The only significant alteration to this ratio was
observed in infected MyD88-/- mice where the percentage of positive CD4+ CD25+
T cells increased to ~12% (Fig. 26C). For CD8+ T cells, the percentage positive
for Sca-1 antigen was 45% and 59% in uninfected MyD88+/+ and MyD88-/- mice,
respectively, which was increased to 84% and 98% in the corresponding infected
groups (Fig. 27A-B). As for CD25 expression, the only significant alteration was
the increase in ratio of positive cells to 5.4% in infected MyD88-/- mice, most
likely a response to an ongoing active infection (Fig. 27C).
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Fig. 26. Increased CD4+ T cell activation in the spleens of MyD88-/- mice following
infection with Salmonella. (A) Expression of Sca-1 and CD25 proteins on gated CD4+ T
cells. Changes in the percent of cells positive for Sca-1 (B) or CD25 (C) are shown.
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The absolute numbers of the myeloid and lymphoid cells were also
determined per spleen. The most noticeable changes in cell number were observed
in the CD11b+ myeloid cell populations. Compared to non-infected spleens, there
were 3-fold and 6-fold increase in these cells in MyD88+/+ and MyD88-/- mice,
respectively (Fig. 28A). Correlating with the chronicity of infection in MyD88-/mice, we observed a 40% increase in splenic myeloid cell number compared to
infected MyD88+/+ counterparts (Fig. 28A). In general, infected spleens also had
increased lymphocyte numbers but to a much lesser extent than the myeloid
population. The increases in lymphocyte populations averaged 30-40% above
those in non-infected spleens for B lymphocytes for both mouse strains (Fig.
28B). For T lymphocytes, the increases in absolute cell number were 44% and
112% in infected MyD88+/+ and MyD88-/- mice, respectively (Fig. 28C).
Therefore, the changes in absolute cell number of myeloid cells are in agreement
with the observed cell percentages calculated from the flow cytometry data.
However, for the B and T lymphocyte populations, the changes in absolute cell
numbers following infection were not as dramatic as for myeloid cells. These
findings confirm the predominance of myeloid cells in the cellular influx into the
spleen, as a result of Salmonella infection.
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Fig. 28. Changes in spleen cellularity expressed in terms of absolute cell counts.
Absolute counts of CD11b+ myeloid cells (A), CD19+ B lymphocytes (B) and CD3+ T
lymphocytes (C) per spleen. Analysis was done on day 21 post-infection with the
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4.10. Dysregulated T helper cells responses in MyD88-/- mice after Salmonella
infection
Given the hyper antibody responsiveness and the dysregulated isotypes
observed in MyD88-/- mice, and the fact that these responses are T cell-dependent,
we compared gene expression profiles of purified splenic CD4+ T (Fig. 29A) cells
isolated from the different experimental groups at day 21 post-infection. The
transcriptional level of IFN-γ was significantly elevated (27-32 fold) upon
infection with Salmonella in both MyD88+/+ and MyD88-/- mice (Fig. 29B). This
was correlated with increased expression of t-bet, the transcriptional factor
responsible for Th1 differentiation (Fig. 29C). Moreover, CD4+ T cells from
infected MyD88-/-, but not wild-type, mice expressed significant levels of IL-4 and
IL-21, signature cytokines of Th2 and TFH cells, respectively. The significant level
of constitutive IL-4 expression in uninfected MyD88-/- mice was noteworthy
which further increased upon Salmonella infection to a level that was 10-fold
higher than infected MyD88+/+ mice (Fig. 29B). Another intriguing difference in
cytokine transcriptional activity was observed with IL-10 which was expressed at
low levels in CD4+ T cells of infected wild-type mice (~2.5-fold over background)
but was significantly elevated (~14-fold) in infected MyD88-/- mice (Fig. 29B).
Finally, no evidence for IL-17 or TGF-β production by CD4+ T cells of any of the
groups was observed. Of all of the transcription factors analyzed, only t-bet was
expressed at high levels by both MyD88+/+ and MyD88-/- CD4+ T cells (Fig. 29C).
No evidence for expression of GATA-3, RoR γ, or Bcl-6 was seen. Curiously,
significant levels of Foxp3 were expressed by CD4+ T cells of non-infected
MyD88-/- mice, but this was curtailed following infection (Fig. 29C). This
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suggests a reduced expansion of the Treg cells in the absence of MyD88 as a
result of a persistent Salmonella infection.
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Fig. 29. Gene expression profiles in purified CD4+ T lymphocytes. (A). Representative
dot plots of splenic CD4+ T cells before and after purification. Gene expression levels of
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Given the increased infiltration of inflammatory myeloid cells into the
spleens of MyD88-/- mice at day 21 of infection, the capacity of purified myeloid
cells (Fig. 30A) to produce inflammatory mediators was assessed. The highest
transcriptional activity observed was for iNOS, which was expressed at >1000fold higher levels in both MyD88+/+ and MyD88-/- myeloid cells compared to
uninfected controls (Fig. 30B). Equivalent levels of induction of IL-6 and IL12p35 were also evident in both mouse strains. Interestingly, a small but
significant level of expression was observed for BAFF, a cytokine associated with
polyclonal B cell responses and autoimmune diseases, in MyD88-/- mice (Fig.
30A). Consistently, this induction was absent in infected wild-type mice.
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In order to validate cytokine production by CD4+ T cells, purified cells were
stimulated with a combination of plate-bound anti-CD3/CD28 mAbs for 24 hours
after which culture supernatants were collected and assayed for IFN-γ, IL-4 and
IL-10 content. In confirmation of gene expression data, CD4+ T cells of infected
MyD88+/+ or MyD88-/- mice secreted abundant levels of IFN-γ reaching up to 14.3
ng/ml and 11.5 ng/ml, respectively (Fig. 31A). In sharp contrast, IL-4 secretion
was detected only from MyD88-/- CD4+ T cells, which is in agreement with the
gene expression findings (Fig. 31C). Interestingly, CD4+ T cells from uninfected
MyD88-/-, but not MyD88+/+, mice could also secrete IL-4 upon induction via the
TCR, suggesting an endogenous predisposition to Th2 responses in these mice
(Fig. 31C). Moreover, high levels of IL-10 (mean of 2174 pg/ml) were uniquely
observed in Salmonella-infected MyD88-/- mice (Fig. 31B). Overall, the data
suggest the prevalence of CD4+ T cells producing both the proinflammatory
cytokine IFN-γ and/or anti-inflammatory cytokines IL-4 and IL-10 in MyD88-/mice, following infection with BRD509. This contrasts with wild-type mice that
exhibit predominantly Th1-mediated immune responses against Salmonella
infection.
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Fig. 31. Evidence of IL-4 and IL-10 production by purified CD4+ T cells in infected
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An important question that was still unanswered by the above data was
whether the proinflammatory (IFN-γ) and anti-inflammatory cytokines (IL-4 and
IL-10) were produced by the same or distinct populations of CD4+ T cells. To
address this issue, we carried out intracellular cytokine analysis by flowcytometry.
Highly purified CD4+ T cells from infected or uninfected mice were stimulated
overnight with anti-CD3/CD28 antibodies and assessed for the intracellular levels
of IFN-γ, IL-4 and IL-10 cytokines. No evidence for any IL-10 production was
observed when CD4+ T cells from any of the 4 experimental groups of animals
were cultured without TCR stimulation (Fig. 32; Control groups). Similarly, less
than 1% of CD4+ T cells in unstimulated cultures were positive for IFN-γ. The
same was also true for IL-4 production (Fig. 33). After TCR ligation, the
percentage of CD4+ T cells from uninfected mice that were positive for IFN-γ was
~2.3% and 0.7% for MyD88+/+ and MyD88-/- mice, respectively (Figs. 33). After
infection, the percentage of cells positive for IFN-γ increased dramatically to 21%
and 30%, respectively. We focused our attention on defining populations of CD4+
T cells that co-expressed both IFN-γ and IL-4 or IFN-γ and IL-10. In infected
MyD88-/- mice, approximately 4.2% of CD4+ T cells were IFN-γ+IL-10+ (Fig. 32
and Fig. 34B). Importantly, there was no evidence for equivalent cells in infected
MyD88+/+ mice. In terms of IL-4/IFN-γ co-expressers, approximately 2% of CD4+
T cells from infected MyD88-/- mice were positive, which was significantly
different from the case in infected wild-type mice (Fig. 33 and Fig. 34C).
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Fig. 32. Co-production of IFN-γ and IL-10 by CD4+ T cells of MyD88-/- mice
following Salmonella infection. Cytokine secretion by purified T cells was detected by
intracellular staining for IFN-γ and IL-10. Purified CD4+ T cells were cultured with or
without overnight stimulation with plate bound anti-CD3/CD28 antibodies and analyzed.
CD4+ T cells were purified from non-infected or Salmonella-infected spleens of WT and
MyD88-/- mice at day 21 post-infection Percent of various cell populations is shown in
each quadrant. The data are representative of three independent experiments.
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To validate the presence of cytokine co-expressers among the peripheral
CD4+ T cell pool in infected MyD88-/- mice, we carried out a similar analysis in a
non-related mouse strain that was deficient in CD154 protein. These mice are
hypersusceptible to Salmonella infection because of a defect in T-cell-dependent
macrophage activation and antibody responses (al-Ramadi et al., 2006). These
mice were infected with a dose of about 0.5 x 106 CFUs/mouse, sacrificed three
weeks later and splenic CD4+ T cells were purified and analyzed by intracellular
staining following CD4+ T cell stimulation, as described earlier. A substantial
percentage (17-18%) of stimulated CD4+ T cells was positive for IFN-γ as
opposed to cells from non-infected mice that exhibited only 1.6% positivity.
Importantly, however, there was no evidence of any IFN-γ/IL-10 or IFN-γ/IL-4
co-expressers among the infected spleens in these mice (Fig. 35). This suggests
that the observed phenomenon in MyD88-/- mice is associated with the
dysfunction of the adaptor molecule at the level of innate immune response to the
intracellular pathogen and hence, possibly the induction of other compensatory
pathways that lead to the expansion of these specialized CD4+ T cells.
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5. DISCUSSION
We and others have previously demonstrated the critical importance of the
TLR-MyD88 pathway in defense against microbial infections (Sukhumavasi et al.,
2008); (Talbot et al., 2009); (Weiss et al., 2004); (Issac et al., 2013). In our
laboratory, mice lacking the MyD88 signaling pathway were shown to be
hypersusceptible even to low doses of an attenuated, double auxotrophic, strain of
Salmonella enterica serovar Typhimurium (S. Typhimurium), as a result of
defective clearance of the pathogen. This is mainly due to the delayed recruitment
of inflammatory cells and defective production of inflammatory cytokines that are
critical for controlling early phase of infection (Issac et al., 2013). In the case of
the facultative intracellular pathogen, S. Typhimurium, susceptibility to infection
was accompanied by the peculiar phenomenon of hypergammaglobulinemia (Issac
et al., 2013). This study is aimed at defining the cellular and molecular parameters
that predispose to dysregulated immunoglobulin synthesis and, by extension,
autoantibody production.
In the present study, the aberrant antibody responses developed within the
context of a strong CD4+ T cell-generated IFN- response combined with a
background of Th2-biased immune responsiveness that was exhibited by MyD88-/mice. Interestingly, small but significant levels of IFN-/IL-4 and IFN-/IL-10 coproducing CD4+ T cells were uniquely observed in Salmonella-infected MyD88-/mice. The dysregulated antibody responses were largely driven by Salmonella
infection in a time and dose-dependent fashion and culminated in production of
antibodies reactive to several types of ubiquitous self-antigens. Given the defect in
B lymphocyte central tolerance observed in infants born with a deficiency in
MyD88 (Isnardi et al., 2008), it is plausible that a similar phenomenon exists in
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MyD88-deficient mice, leading to the production of potentially self-reactive B cell
clones. As a result of delayed clearance of bacteria, persistent Salmonella
infection could lead to the activation of idle autoreactive B cells in MyD88-/- mice.
This could also lead to the expansion of distinct populations of IFN-γ+ T cells and
extrafollicular CD4+ T helper cells that possibly activate aberrant B cell responses
and autoantibody production.
5.1. MyD88 signaling is crucial for early phase control of bacterial growth
The BRD509 strain of S.Typhimurium has a slow growth rate due to the
inability to synthesize essential aromatic compounds. In the early phase of
infection, the survival and growth of Salmonella in C57BL/6 mouse is determined
by the induction of SPI-2 encoded virulence factors (Cirillo et al., 1998); (Pfeifer
et al., 1999). The innate immune response that involves the bactericidal effector
function as a result of activation of the host macrophages, plays a vital role in the
control of the proliferation of the pathogen. Although TLRs have a critical role in
protection against bacterial infections, there is data that suggests that S.
Typhimurium can exploit the TLR signaling in macrophages for enhanced
intracellular replication and survival. One study demonstrated that treatment of
macrophages with various TLR agonists, like LPS, poly (I:C), peptidoglycan or
CpG, increased bacterial uptake and enhanced Salmonella survival (Wong et al.,
2009). In another study, Salmonella bacteria were shown to exploit recognition by
TLR9 on macrophages to enhance their virulence. This was shown to be mediated
through TLR-dependent acidification of SCV which in turn, upregulates several
T3SS genes necessary for bacterial survival, replication and virulence (Arpaia et
al., 2011a). In a third report, concomitant infection with an attenuated strain of
Salmonella was found to aggravate infection with a virulent strain of Salmonella.
124

This is mediated by TLR4-induced production of IL-10 triggered by the
attenuated bacteria which in turn, exacerbates infection by the virulent strain
(Foster et al., 2008).
Neutrophils play a critical role as the first line of innate immune defense
against Salmonella (Conlan, 1997). In response to Salmonella infection in the
early phase, several anti-microbial defense mechanisms are activated, which
mainly involves the recruitment of neutrophils and other phagocytic cells to the
site of infection as well as induction of their microbicidal effector functions
(O'Brien et al., 1980); (Royle et al., 2003). TLRs promote the bactericidal activity
of macrophages against Salmonella through increased cytotoxic activity and
TNF-α production (Weiss et al., 2004). In our model, the delayed recruitment of
inflammatory cells, consisting mainly of granulocytes, at the site of infection is
apparent at 24 hours. Though we have not assessed the exact role of MyD88 in
inflammatory cell recruitment, other studies have highlighted its critical function
in chemokine expression that coordinate early phagocyte response (Bandow et al.,
2012) (Rydstrom and Wick, 2009). MyD88/TLR4-dependent chemokine
expression of CCL2, CXCL9 and CXCL2 is crucial for neutrophil and monocyte
recruitment following oral infection with Salmonella (Rydstrom and Wick, 2009).
By 48 hours, the bacteria start to mobilize to the target organs in MyD88+/+ mice,
leading to a further reduction in polymorphonuclear cells by 72 hours. In contrast,
bacterial CFUs and neutrophil recruitment continue to expand in MyD88-/- mice at
72 hours post-infection in the peritoneal cavity. As early as 48 hours postinfection, MyD88-/- mice display defect in phagocytic cell recruitment and
proinflammatory cytokine production, such as IL-6, IL-12 as well as antimicrobial
effectors like nitric oxide (Fig. 3C-E) (Issac et al., 2013). These defects may well
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contribute to MyD88-/- mice being susceptible to infection. Even up to 10 days
post-infection, the accumulation of these cells was more reduced in MyD88-/- mice
than TLR2/4-/- mice (Seibert et al., 2010). Ko and colleagues (Ko et al., 2011) in
their findings have shown accumulation of inflammatory myeloid cells at 4 weeks
post oral administration of recombinant attenuated S. Typhimurium (RASV) strain
with increased levels of inflammatory cytokines, resulting in systemic
inflammation in MyD88-/- mice. The substantial delay in the recruitment and
activation of phagocytic cells in MyD88-/- mice could be a major contributor to the
increased host mortality observed in our study (Fig. 20, 21). Despite this delay,
the fact that phagocytic cell infiltration occurs indicates the initiation of other
signaling pathways as a substitute for MyD88.
TLR signaling has also proven to be critical in Gram-positive intracellular
infections like L. monocytogenes where bacterial titers were higher in the organs
of TLR2-/- and MyD88-/- mice than control mice. There is decreased activation of
TLR-deficient macrophages and dendritic cells on L.monocytogenes infection
leading to substantially reduced production of TNF-α, IL-12 p40 and nitric oxide
(Torres et al., 2004). Studies with intracellular facultative Gram-negative bacterial
infections of S. Typhimurium (Talbot et al., 2009) and Ehrilichia muris (Koh et
al., 2010) in MyD88-deficient mice display enhanced bacterial numbers in the
target organs and blood. Neutrophil recruitment is MyD88-dependent in early
phase infections even with other intracellular pathogens (Sukhumavasi et al.,
2008); (Koh et al., 2010); (Lebeis et al., 2007). By 21 days post-infection with S.
Typhimurium, the percentage of myeloid cells was substantially higher in infected
MyD88-/- spleens (Fig. 21A) which leads to lower percentages of lymphoid cells
(Fig. 22B, 24B). The total splenic myeloid cells recovered were significantly
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higher when compared to those of the wild-type infected mice. However we did
not observe any dramatic changes in the absolute numbers of lymphocyte
populations. In contrast, Ko and coworkers reported substantial increase in
lymphoid and myeloid populations in MyD88-/- spleens compared to those of
wild-type mice at 4 weeks post oral infection with Salmonella (Ko et al., 2011). In
addition to the increased myeloid cell numbers in the spleen of Salmonella
infected MyD88-/- mice, the increased spleen weights in these mice could be
contributed by the enhanced erythropoiesis in the spleen to the growing
Salmonella infection (Jackson et al., 2010).
The production of IL-12, IL-6 and nitric oxide by myeloid cells of mice
lacking MyD88 at late stage of Salmonella infection suggests the induction of
these cytokines in a MyD88-independent manner, possibly driven through TLR4triggered TRIF pathway. Yamamoto et al (2003) demonstrated that LPS-induced
secretion of IL-6, IL-12 and TNF-α was abrogated in macrophages from TRIF-/mice. Furthermore, proliferative responses of splenocytes to LPS were severely
impaired in these mice (Yamamoto et al., 2003). IFN-α and IFN-β production
through the TRIF mediated pathway leads to nitric oxide release in response to
Salmonella LPS (Zughaier et al., 2005). Moreover TLR-independent intracellular
PRRs, such as NLRs, are involved in the production of inflammatory cytokines
and development of adaptive response to Gram-positive (Fritz et al., 2007) and
Gram-negative bacteria (Geddes et al., 2010). Nod1 and Nod2 provide effective
antibacterial inflammatory responses (IL-1β, keratinocyte derived chemokine) and
induce generation of enteric Th17 responses to Salmonella infection (Geddes et
al., 2010); (Geddes et al., 2011). Peptidoglycan recognition by Nod1 directs Th1,
Th2 and Th17 responses (Fritz et al., 2007). Another MyD88 independent
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mechanism is complement activation which on sensing LPS of Gram-negative
bacteria generates anaphylatoxins that induce inflammatory responses (Winter et
al., 2010).
5.2. TLR signaling in IFN-γ production and T cell mediated immune response
Control of Salmonella infection requires strong T cell responses involving
both CD4+ and CD8+ T lymphocytes (al-Ramadi et al., 2006); (Hess et al., 1996);
(Mittrucker and Kaufmann, 2000). The CD4+ Th1 response in Salmonella infected
mice is characterized by inflammatory cytokine secretion, particularly IFN-γ (Pie
et al., 1997); (Kaufmann, 1993); (Mastroeni, 2002). Deficiencies in IL-12 and IL12-dependent production of Th1 cytokines, such as IFN-γ and TNF-α, caused
profound susceptibility to Salmonella infection in mice (Jouanguy et al., 1999);
(Tite et al., 1991) and predisposition to Salmonellosis in humans (de Jong et al.,
1998); (Altare et al., 1998). During the early stage of infection, NK cells are the
major source of IFN-γ which is necessary for macrophage activation and effective
protection to Salmonella (Ramarathinam et al., 1993). In infected MyD88deficient mice, the IL-12 response was severely impaired in the acute phase
between 2-48 hours of Salmonella infection (Fig. 3D) (Issac et al., 2013). Despite
the observed defect in IL-12 production at 48 hours post-infection, comparable
levels are detected at three weeks post-infection in wild-type and MyD88-/- mice.
The production of IL-12 also correlates with IFN-γ production. The Th1
dependent induction of IFN-γ at three weeks post-infection was at substantially
high levels, comparable to those of immunized MyD88+/+ mice (Fig. 34A). In
experimental models of other intracellular pathogens, the early acute IFN-γ
release from splenocytes was MyD88 dependent (Naiki et al., 2005) but the Th1induced cytokine response eventually developed with time in MyD88 -/- mice
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(Sukhumavasi et al., 2008). A robust Salmonella-specific T cell memory response
developed in MyD88-/- mice following infection with a sublethal dose of BRD509
strain. However, memory T cells failed to provide effective protection to
immunized MyD88-/- mice as they remained susceptible to virulent challenge. The
overall mortality was much higher when compared to the immunized wild-type
mice. This lack of effective protection in the absence of MyD88 further highlights
the critical role of phagocytes in the control of Salmonella bacterial proliferation
(Issac et al., 2013). A recent study demonstrated that neutrophils are able to
produce IFN-γ in response to intracellular pathogens, including Salmonella, in
mice with TLR11-deficiency. In this report, IFN-γ production by neutrophils was
regulated by TNF-α and IL-1β (Sturge et al., 2013). MyD88 is a crucial
component of the signaling pathway of IL-1R and IL-18R. IL-1β and IL-18 are
potent activators of the acute phase of anti-bacterial host defense (Adachi et al.,
1998a) through activation of NK cells (Chaix et al., 2008); (Raupach et al., 2006)
and development of Th1 responses (Takeda et al., 1998). IL-18 was shown to be
required for essential clearance of bacteria and to be involved in the secretion of
IFN-γ by CD4+ T cells of Salmonella infected mice (Srinivasan et al., 2007).
Despite the evidence of Th1 responses, the increased susceptibility of MyD88-/mice to Salmonella infection could also be explained by the lack of IL-1β and
IL-18 signaling as a result of the loss of MyD88.
5.3. TLR signaling in B cell mediated adaptive immune response to infection
The role of TLRs in the induction of antibody responses is controversial.
Antigen-specific antibody responses have been reported to depend on TLR
activation on B cells (Chandrashekhar and Ruslan, 2005). However, there are
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several other studies that have highlighted the importance of signaling through
TLRs for the control of the pathogen but not for the induction of adaptive immune
responses (Gavin et al., 2006); (Ko et al., 2009). B cells express most TLRs
(Dasari et al., 2005); (Rawlings et al., 2012) and notably TLR engagement
promotes B cell proliferation, survival and differentiation to long lived antibody
secreting plasma cells (Gerondakis et al., 2007); (Gray et al., 2007); (Boeglin et
al., 2011);(Ruprecht and Lanzavecchia, 2006). TLR4 promotes B lymphocyte
maturation while TLR2 arrests the process (Hayashi et al., 2005). Some TLRs
have also been suggested to have a role in the early stages of B cell development
(Applequist et al., 2002). TLR signaling has proven to be essential for generation
of antibody secreting plasma cells in both the spleen and bone marrow in MyD88 /-

mice after influenza VLP vaccination (Kang et al., 2011). The expression of

TLRs varies during B cell development and increased antibody production has
been demonstrated on TLR activation of terminally differentiated plasma cells in
humans. In our study, the loss of MyD88 did not affect B cell numbers in naïve
mice (Fig. 22B) which is in agreement with other studies (Adachi et al., 1998b);
(Kawai et al., 1999). In an experimental system utilizing mice with MyD88
deficiency restricted to the B cell compartment (MyD88B-/-), Salmonellaimmunized animals possess fewer and smaller germinal centers (GCs) than those
of wild-type mice, thus suggesting that GC B cell differentiation is also dependent
on TLR signaling (Barr et al., 2009). Direct TLR-induced activation of human B
cells also leads to expression of a large number of cytokines (Agrawal and Gupta,
2011); (Jagannathan et al., 2009). On the other hand, at 4 weeks post oral
administration of RASV, GC formation was increased in MyD88-/- mice when
compared to wild-type mice (Ko et al., 2011). Thus, B cell-specific loss of
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MyD88 affects their activation in GCs, while total MyD88 deficiency seems to
not adversely affect B cells in GCs, suggesting that MyD88 functions in different
capacities depending on the cell type.
One of the main findings in our study is the observed phenomenon of
hypergammaglobulinemia. Wild-type mice in response to Salmonella infection,
typically exhibit humoral immune response skewed by Th1 type cytokines.
Following infection with attenuated Salmonella, antibodies of IgG2c and IgG3 are
the predominant isotypes being produced in C57BL/6 mice (al-Ramadi et al.,
2006); (Issac et al., 2013) or isotypes of IgG2a and IgG3 in BALB/C mice
(Harrison et al., 1997). In addition to the cytokine-induced Ig isotype switching,
interaction between TLR9 expressed on B cells and pathogen ligands has been
shown to induce IgG2a class switching. Interaction of pathogen with ligands can
directly activate B cells, possibly explaining as to why they generally induce
strong IgG2a responses (Jegerlehner et al., 2007). In contrast to wild-type mice,
MyD88-/- mice irrespective of the route of Salmonella infection, in response to
Salmonella infection developed aberrant humoral immune response with antiSalmonella antibodies of all isotypes being produced at high levels, establishing a
state of hypergammaglobulinemia (Fig. 4). Infection with B. Burgdorferi bacteria
induced IgM hypergammagobulinemia along with IgG1 and IgE activated
responses in the absence of MyD88 (Woods et al., 2008). Interestingly, uninfected
MyD88 deficient mice exhibited high levels of total IgG1 antibody subclass in
their serum which were largely unchanged after infection (Fig. 7C). The clear
dominance of Th2-biased adaptive immune response is confirmed by high levels
of IL-4 in the MyD88-/- mice. In hygienic conditions, the immune response is
predisposed to a Th2 response which shifts to a Th1 response on exposure to a
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pathogen. In the absence of MyD88 the Th2 profile remains intact. The
predominant Th2 profile could be associated with the inability to respond to
pathogens in the absence of TLR signaling. The lack of MyD88 undermines the
exposure to pathogen naturally acquired through air or water, maintaining the de
facto Th2 response. Moreover, the influence of these responses by commensal
bacteria can be evaluated by continuous treatment with antibiotics from birth in
both MyD88+/+ and MyD88-/- mice for up to 8-12 weeks. Following this, CD4+ T
cells can be purified and levels of IL-4 can be determined. This will clarify any
role of the commensals in driving the de facto Th2 responses. Several animal
models of infection have highlighted the development of Th2 responses due to
MyD88 deficiency (Chen et al., 2010); (Debus et al., 2003); (Liu et al., 2004); (Ko
et al., 2009). Ko and colleagues reported that signaling through MyD88 is
dispensable for the induction of LPS-specific B cell responses. Moreover they
demonstrate decreased IgG2a:IgG1 antibody responses (Ko et al., 2009).
Similarly, in another study, IgG1 response to T-cell dependent antigens took place
independently of MyD88 signaling along with loss of IgG2c in mice with MyD88deficient B cells infected with Salmonella (Barr et al., 2009). Our data are
consistent with these findings of a Th2 induced IgG immune response (Issac et al.,
2013). However these levels were inevident in MyD88-/- mice that possessed
reduced isotype switched IgG antibodies on immunization with influenza viral
particles (VLP), as a result of defective secretion of antibodies from splenic B
cells (Kang et al., 2011). Interestingly, DCs have been claimed to support Th2 cell
development in the absence of TLR signaling (Kaisho et al., 2002). This was not
the case in another study where MyD88 signaling in Gr-1+CD11b+ myeloid cells
facilitated Th2 polarized B cell responses in a polymicrobial sepsis model (Delano
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et al., 2007). Overall, a controversial role of MyD88 signaling in controlling B
cells responses is portrayed.
Even infection with cytokine expressing strains of attenuated Salmonella
failed to influence the trend of dysregulated antibody titers following infection in
MyD88-/- mice (Fig. 17). Interestingly, this phenomenon of uncompromised
antibody response was not observed in MyD88-/- mice infected with other Gramnegative bacteria like A. baumanii or E. coli or Gram-positive bacteria like GpB
Streptococcus or even with heat-killed BRD509 (Fig. 15C-E, Fig. 15). Though an
exaggerated humoral immune response was generated to Salmonella infection in
the MyD88-/- mouse strain, this failed to provide effective protection to control the
bacterial growth, further underlining the crucial role of the innate immune cells in
the early phase of infection. In certain infections like B. burgdorferi, the antibody
response to the pathogen appeared to control the bacterial burden substantially in
MyD88-/- mice (Liu et al., 2004). The antibody responses mounted in the absence
of MyD88 could be through compensatory alternative sensory pathways being
activated in response to the pathogens. One such mechanism is through NLRs
particularly Nod1 and Nod2 that potentiate the generation of antigen-specific
adaptive immune responses to bacterial ligands. This involves antigen specific
immunoglobulin production and induction of optimal T cell response of Th1 or
Th2 pathway (Fritz et al., 2007); (Kobayashi et al., 2005).
Stimulation of purified CD4+ T cells from spleen or lymph node after
infection, produced prominent IFN-γ levels in wild-type mice and IL-4 levels in
MyD88-deficient mice (Koh et al., 2010); (Muraille et al., 2003). These
observations were conflicting in our study following Salmonella infection where
we confirm the production of strong IFN-γ levels in MyD88-/- mice similar to
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those in the wild-type mice (Fig. 31A). The increased presence of IFN-γ on
infection contributed to increased expression of Sca-1 activation markers in the
myeloid and lymphocyte populations in the spleen (Fig. 21B, 24A, 26A, 27A).
Furthermore, an aberrant induction of IL-4 was also observed in MyD88-/- mice
after infection with attenuated Salmonella (Fig. 29A). These levels observed at the
RNA level were further confirmed with intracellular FACS staining and cytokine
levels obtained after ex vivo restimulation of CD4+ T cells (Fig. 31B, 34B). The
induction of increased amounts of both IFN-γ and IL-4 in MyD88-/- mice
coincides with the presence of prominent levels of cytokine-driven antibody
isotypes after infection with Salmonella. Interestingly, Neves and colleagues
reported stronger NK and T cell responses to Salmonella in mice with B cellspecific MyD88 deficiency (MyD88B-/-) than those in wild-type animals (Neves et
al., 2010). The stronger anti-Salmonella response was correlated with reduced
production of IL-10 by the activated B cells in MyD88B-/- mice, demonstrating a
potentially important regulatory role for B cell-specific IL-10 synthesis.
5.4. Breakdown of self-tolerance as result of loss of MyD88
MyD88/IRAK deficiency in humans was first identified in 2003 (von
Bernuth et al., 2012). The adaptor molecule is crucial for infancy survival and
early adulthood. Similar to MyD88-/- mice, patients deficient in MyD88/IRAK-4
had increased susceptibility to infections with invasive pyogenic Gram-positive
and Gram-negative bacteria (von Bernuth et al., 2008); (von Bernuth et al., 2012).
The signaling proteins are more crucial during childhood. With age, infections in
patients that lack these signaling molecules are rarer, probably due to adaptive
immune responses from B and T lymphocytes (Picard et al., 2010). MyD88 is
vital for the negative selection of autoreactive immature B cells in the bone
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marrow. MyD88 and IRAK-4 deficient patients exhibited increased ratios of
autoreactive B cells and high frequency of HEp-2 reactive clones (Isnardi et al.,
2008). This strongly implies a disruption of the B cell activation pathway and a
breakdown of central tolerance in the absence of MyD88 signaling. However, no
ANA or other polyreactive antibodies were detectable in sera collected from these
patients within 3 months after birth (Isnardi et al., 2008). This could suggest either
of two possibilities; one that TLR7/9 signaling that enhances costimulatory signal
on BCR recognition of immune complexes gets thwarted and second that certain
infections can breakdown self-tolerance as a result of loss of MyD88. As
explained earlier, various experimental models have proved that infections can
lead to autoimmunity (Tardieu et al., 1984); (Wucherpfennig, 2001); (Fairweather
et al., 2001). Our findings show B cell hyper activation in mice with defective
MyD88 signaling caused an aberrant and dysfunctional humoral immune response
of all isotypes against the Salmonella antigens with high affinity to autoantigens
such as dsDNA, thyroglobulin and other nuclear antigens (Fig. 10, 11). These
antibodies also formed immune complexes in the glomerular membrane of the
kidney (Fig. 12). Similar findings have been reported by Ko et al (Ko et al., 2011).
In our study, infection with other Gram-negative pathogens though harboured
higher bacterial counts in the MyD88-/- spleen, failed to mount any phenomenon
of hypergammaglobulinemia with autoantibody production (Fig. 14). This
suggests that specific properties of Salmonella organisms such as their mode of
survival and replication in the intracellular compartments of the macrophages may
be responsible for the observed auto reactivity in MyD88-deficient mice. The
chronic infection of Salmonella in MyD88-deficient mice could probably disrupt
the anergic state of the autoreactive B cells, leading to the observed production of
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antibodies to nuclear antigens. In one study, administration of poly(I-C)
highlighted the role of MyD88 independent signalling in the development of
autoimmunity in lupus prone mice deficient in MyD88. This has been associated
with increased levels of IFN-α jointly with IL-6 and IL-12 (Sadanaga et al., 2007)
Contrary to this is the involvement of MyD88 in the pathogenesis of
autoimmunity in various autoimmune mouse models. In MRL/lpr mice, MyD88
signaling in B cells mainly contributed to ANA and RF formation (Teichmann et
al., 2013). Loss of MyD88 in MRL/lpr mice reduced immunoglobulin serum
levels and anti-dsDNA antibody titres with reduced inflammatory lesions thus
improving the survival of the mice (Sadanaga et al., 2007). Viral and bacterial
infections

have

been

known

to

drive

polyclonal

B

cell

activation,

hyperglobulinemia and possible reactivity to self-antigens from chronic infections
(Soulas et al., 2005); (Jellison et al., 2007). This non-specific B cell activation can
be through direct activation by B cell mitogens or peptide derived interaction with
CD4+ T cell irrespective of the specificity of BCR (Stevenson and Doherty, 1999);
(Hunziker et al., 2003). Furthermore, MyD88 expression in RF B cells is required
for their initial activation and expansion in responses to IgG2a anti-chromatin
(Herlands et al., 2008). With the activation of autoreactive B cells in the primary
step of autoimmunity, the role of TLR signals in mediating these responses has
been comprehended.
As mentioned previously, elevated levels of BAFF have been associated with
increased survival of autoreactive B cells in the periphery (Lesley et al., 2004);
(Mackay et al., 2003); (Thien et al., 2004). Though BAFF has no role in the
elimination of high affinity self-reactive B cells in the bone marrow, peripheral
deletion of autoreactive B cells has been found to be rescued by increased
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expression of BAFF protein and hence, permit their entry to forbidden
microenvironments of the spleen. Furthermore, the rescued self-reactive B cells
that partially expressed CD86 were adequate for its response to antigenic
stimulation leading to autoantibody production (Thien et al., 2004). IFN-α has
been well established in the pathogenesis of SLE (Ronnblom and Alm, 2001);
(Barrat et al., 2005); (Pascual et al., 2003) and IFN-α/β has been known to
upregulate the expression of BAFF in autoimmune mouse models (Jacob et al.,
2011) as well as in humans (Krumbholz et al., 2008); (Litinskiy et al., 2002); (Yao
et al., 2009). Other than exercising MyD88 as the adaptor molecule, TLR-4 can
signal through TRIF for the induction of Type1 IFN genes (Yamamoto et al.,
2003). Thus we suggest if this pathway could be triggered as a compensatory
route in the absence of MyD88, due to enhanced bacterial burden. In our results,
evaluation of BAFF expression revealed increased levels of the B cell activating
factor being expressed as a result of loss of MyD88 in the myeloid cells of the
spleen by 3 weeks post-infection in the mouse strain (Fig. 30A). Ko and
colleagues in their findings have shown increased levels of expression of BAFF
and APRIL in the spleen of MyD88-/- mice at two days, following oral
administration of RASV strain (Ko et al., 2009). In one study, the presence of
undigested mammalian DNA has also been implicated in the activation of Type I
IFN genes (Okabe et al., 2005). Nickerson and colleagues in their study of the role
of

TLR7/9

in

regulating

autoimmunity,

observed

dermatitis

and

hypergamaglobulinemia even in MyD88 deficient animals, further suggesting
possible contributions of MyD88 independent components such as PRRs, that
recognise nucleic acids like RIG-I or MDA or other nucleic acid sensory pathways
(Nickerson et al., 2010).
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IL-17 has been known to be involved in the pathogenesis of various
inflammatory autoimmune diseases (Zhu and A Qian, 2012), one of which is its
synergistic effect with BAFF in promoting B cell survival in SLE (Doreau et al.,
2009). However, there was no apparent induction of IL-17 or its regulatory protein
in MyD88 deficient mice, to chronic Salmonella infection in our observations
(Fig. 29) excluding its role in the observed autoimmune response as a result of
self-tolerance breakdown. Furthermore, the reduction in the expression of Foxp-3
in CD4+ T cells of infected MyD88-/- mice when compared to MyD88+/+ mice
suggests dependency of Tregs on MyD88 signaling in response to infection (Fig.
29B). This further implies a decreased Treg mediated suppression of immune
responses, particularly T cell expansion to infection.
A distinct population of B helper T cells first identified in tonsils (Breitfeld et
al., 2000) is localized in the B cell zone of lymphoid organs and has been
associated with various autoimmune diseases in humans (Simpson et al., 2009);
(Ma and Deenick, 2013). IL-6 and IL-21 proinflammatory cytokines along with
costimulatory molecule stimulation are involved in the differentiation of this
specialized subset of T cells called TFH cells. PD-1 and CXCR5 are upregulated in
TFH cells, the latter of which is crucial for its migration to the B cell follicle (Park
et al., 2014). These cells are regulated by the transcription factor B cell
lymphoma-6 (bcl-6) and secrete IL-4 and IL-21 that promotes B cell somatic
hyper mutation, affinity maturation, Ig isotype switch and plasma cell
differentiation. IL-21 directly acts on B cells in germinal centers (Zotos et al.,
2010) to regulate Bcl-6 expression for affinity maturation of B cells (Linterman et
al., 2010). IL-21 deficient mice immunized with T-dependent antigen showed
defect in affinity maturation of plasma cells and formed abnormal germinal
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centers. The abnormal GC development however, was not associated with
unaffected TFH cells suggesting mainly the prerequisite of IL-21 in GC reactions
and not TFH cell development (Zotos et al., 2010). Although Tfh cell formation is
IL-21 independent, the maintenance of this T cell subset is impaired in the
absence of the cytokine (Linterman et al., 2010). TFH cells facilitate the survival
and differentiation of self-reactive B cells, eventually leading to autoantibody
production and organ damage (Zhang et al., 2013). The dysregulation of TFH and
extrafollicular Th cells has been linked to chronic autoimmunity in several
autoimmune murine models (Odegard et al., 2008); (Park et al., 2014). Despite the
fact that Bcl-6 suppresses differentiation of other T helper cells, increased levels
of IFN-γ have been reported to promote accumulation of TFH cells in sanroque
mouse model (Lee et al., 2012). Three weeks after infection with attenuated
Salmonella in MyD88-/- mice, a significant expression of IL-21 was observed, but
with no evidence of Bcl-6 in splenic CD4+ T cells (Fig. 29). Lack of Bcl-6
expression could possibly reflect a late stage of TFH cell differentiation (Ma and
Deenick, 2013). One study has also shown a downregulation of Bcl-6 expression
in some murine TFH cells (Kitano et al., 2011). The extrafollicular T cell zone in
the spleen was found to be a region of spontaneous autoantigen responses.
Extrafollicular T helper cells promote the formation of somatic mutated
autoantibodies in MRL/lpr mice in the extrafollicular sites of B cell proliferation
(Odegard et al., 2008). Low transcriptional levels of CXCR5 in the splenic CD4+
T cells of MyD88-/- mice (Fig. 29) suggest these to be extrafollicular T helper cells
that contribute to antibody class switched isotypes and autoantibody production
through IL-21 (Odegard et al., 2008). There was a dramatic reduction in the
accumulation of B and T cells in the spleens of IL-21R-/- MRL/lpr mice along
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with decreased B cell activation and autoantibody production (Rankin et al.,
2012). In support of our findings of increased populations of CD11b+Gr-1+
myeloid cells with enhanced activation in the spleens of MyD88 -/- mice following
infection (Fig. 28A) (Fig. 21), are the results of Ko and colleagues (Ko et al.,
2011). They suggest that the increased infiltration, expansion and activation of
myeloid cells in the spleen could modulate proliferation of T FH like cells that
include TFH cells and extrafollicular helper T cells, resulting in hyper IgG
responses in chronic Salmonella infection. Though IL-6 production from
inflammatory myeloid cells was involved in TFH cell differentiation in MyD88-/mice (Ko et al., 2011), in our results with intraperitoneal infection at day 21, the
cytokine was produced at significantly high levels in both the wild-type and
MyD88-/- mice (Fig. 30). This suggests involvement of other candidate cytokines
in TFH cell development. Alternatively, in a study with lupus mice the frequency
of TFH cells as well as IFN-γ producing CD4+ T cells were substantially reduced in
MyD88 deficient B cell and DCs (Teichmann et al., 2013). Expansion of IFN-γ
secreting CD4+ T cells and IL-21 producing extrafollicular T helper cells is one
important feature in MRL/lpr mice (Rankin et al., 2012); (Odegard et al., 2008).
An intriguing observation in our results is the generation of a population of CD4+
T cells on infection with Salmonella in MyD88-/- mice that produce both IFN-γ
and IL-4. These double positive cells were not observed in the infected spleens of
wild-type mice and the non-infected MyD88-/- mice (Fig. 33, 34C). A study with
intramacrophage parasitic infection, recovered CD4+ T cells that are capable of
producing both IFN-γ and IL-4 to the infection in the draining lymph nodes
(Reiner et al., 1994) which were later confirmed to be TFH cells (Reinhardt et al.,
2009). In our study, TFH like cells seem to be generated as a result of persistent
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infection of Salmonella. In one report, persistent viral infection was shown to
induce the differentiation of Th cells to TFH cell responses (Fahey et al., 2011). In
our study, the enhanced induction of IFN-γ was confirmed by the increased level
of its master regulator, T bet. However, this was not the case with GATA-3 that
was thought to regulate the observed IL-4 T cell responses (Fig. 29). Migration of
T helper cells to the extra follicular sites and expression of CXCR4 are largely
dependent on ICOS costimulation. ICOS-/- MRL/lpr mice developed reduced class
switched antibodies and autoantibody titers (Zeller et al., 2006); (Odegard et al.,
2008). The levels of expression of CXCR4, ICOS and PD-1 in the CD4+T cells
are yet to be assessed through PCR and intracellular staining in order to obtain
further understanding of the accumulation of TFH cells and extrafollicular T helper
cells and their respective contribution to the hyper antibody responses. This
further highlights therapeutic approaches of targeting T helper 1 (Th1) cells and
TFH cells in treating antibody mediated diseases.
Infection with GIDIL2/GIDIFN leads to hyper IgG responses in MyD88-/mice but failed to induce any significant autoantibody production, as observed
with BRD509 infected MyD88-/- mice (Fig. 17, 18). This could be related to the
persistence and chronicity of infection with BRD509 in the defective mouse
strain. The IFN-γ and IL-2 expressing strains of Salmonella are cleared more
effectively in the wild-type mice (Al-Ojali et al., 2012a); (Al-Ojali et al., 2012b);
(al-Ramadi et al., 2004); (al-Ramadi et al., 2002). IL-2 expression in the bacteria
improves NK cell cytotoxicity and IFN-γ production and, hence, increases the
synthesis of anti-Salmonella effector molecules such as NO (al-Ramadi et al.,
2003). On the other hand, several studies have also highlighted the role of IL-2 in
enhancing the suppressive activity and expansion of Treg cells (de la Rosa et al.,
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2004); (Thornton et al., 2004). The delivery of IFN-γ by Salmonella strain could
further promote Th1 cell mediated responses thereby downregulating TFH /Th2
cell expansion and function.
During chronic infections, CD4+ T cells that secrete both IFN-γ and IL-10
have been identified which are absent during normal conditions. There is evidence
indicating the suppressive role of these double positive cells in controlling
immune responses through IL-10 with IFN-γ help (Flores-García et al., 2011);
(Liu et al., 2009). These functionally distinct CD4+ T cells identified in an
infection with intracellular pathogen T. gondii display both Th1 effector function
as well as regulatory activity. The IL-10+IFN-γ+ CD4+ T lymphocytes when
cultured with the parasite infected IL-10 deficient macrophages were able to
control the intracellular T. gondii proliferation, effectively highlighting its effector
function. However, the IL-12 production from infected macrophages was
significantly reduced in the presence of these double positive cells (Jankovic et al.,
2007). In one study involving a murine model of L. major, secretion of IL-10 by
Th1 cells prevented the effective elimination of the pathogen contributing to
chronic infection (Anderson et al., 2007). Conditions that drive a highly polarized
Th1 response were found to induce the appearance of these apparent regulatory
cells (Jankovic et al., 2007). In our infection model, IL-10+IFN-γ+ CD4+ T cells
were found to be induced only in MyD88-/- mice after infection and not in wildtype mice or MyD88-/- uninfected mice (Fig. 32, 34B). Also, there was no
evidence for IL-10+ or IL-4+ cells in CD154-/- mice. The presence of a chronic
Salmonella infection in MyD88-/- mice due to their inability to effectively clear the
infection could probably generate these double producer cells. These cells could
also contribute to the prolonged persistence of the bacteria. We have only
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observed the presence of this distinct population of cells but their regulatory role
to the persistent infection is yet to be elucidated.
Overall, our data demonstrate the crucial role of MyD88 mediated TLR
signaling in regulating immune response against S. Typhimurium and its
importance in maintaining self-tolerance in B lymphocytes.
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